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Abstract 
We previously determined that fish oil induced hyperlipidemia in F 1 B hamsters. In this 
study, we investigated the influence offish oil enriched diets on lipid and lipoprotein 
metabolism in F1B and GS hamsters to determine if the response was preserved within 
animal strain. Hamsters were fed either fish oil, a diet high in monounsaturated fatty 
acids, or a diet with an n-6:n-3 fatty acid ratio of 5. Fish oil induced hyperlipidemia to a 
much greater extent in F1B compared toGS hamsters. Fish oil fed F1B hamsters had 
milky plasma containing chylomicron-like particles which was not observed in GS 
hamsters. The concentration of plasma cholesterol, triglycerides, free cholesterol, and 
cholesterol esters were significantly higher in fish oil fed F 1B hamsters compared to GS 
hamsters. Feeding a diet with an n-6:n-3 ratio of 5 markedly decreased all lipid 
parameters in F 1 B and GS hamsters compared to the fish oil diet. However, this diet 
increased LDL-cholesterol concentrations compared to the diet rich in monounsaturated 
fatty acids, suggesting that even a small amount of fish oil in the diet has a deleterious 
effect on the plasma lipoprotein profile. The presence of milky plasma, and elevated 
triglyceride concentrations suggested an inhibition of clearance of triglyceride-rich 
lipoproteins in F1B hamsters. Thus, we investigated the activity ofLPL, MTTP, LDL-
receptor mRNA expression, and the protein expression of apoB and apoE to determine if 
diet or animal strain had an effect on these aspects of lipoprotein clearance .. LPL activity, 
MTTP activity, and LDL-receptor mRNA expression were unaffected by diet, however 
LPL activity was lower in F 1B hamsters. In addition, the protein expression of apoB and 
apoE were altered by both diet and animal strain. In conclusion, comparison ofF 1 B and 
GS hamsters allowed us to attribute the fish oil induced hyperlipidemia to diversity in 
animal strain. 
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Chapter 1 
Introduction 
1.0 The Atherogenic Lipoprotein Phenotype 
The atherogenic lipoprotein phenotype (ALP) is a collection of pro-atherogenic 
lipoprotein abnormalities which include moderately raised fasting triglyceride (TG) 
concentrations (1.5-4mmol/L), decreased high density lipoprotein (HDL)-cholesterol 
f~} _, .. 
(<l.lmmol/L), and the predominance of small, dense low-density lipoprotein (LDL) 
particles, estimated to represent greater than 40% of total plasma LDL (Austin, 1988; 
Minihane et al., 2000; Khan et al., 2002). The observed hypertriglyceridemia is a direct 
result of defects in TG metabolism. Impaired clearance of TG-rich lipoproteins and more 
than adequate lipid substrates for the production of TG aids in an increase in the secretion 
ofhepatic TG-rich very-low-density lipoprotein (VLDL) (Packard & Shepherd, 1997). In 
addition, elevated plasma TG levels results in a shunting ofTG to LDL and HDL, 
lipoproteins that do not normally carry large amounts ofTG. 
The presence ofTG-rich LDL is due to the facilitated catabolism ofLDL by 
hepatic lipase. The resultant LDL particle is smaller and denser than the usual LDL 
particle. It has been reported by several investigators that the predominance of small, 
dense LDL particles is an independent risk factor for the development of cardiovascular 
disease (CVD), mainly due to an increase in oxidative susceptibility further contributing 
to foam cell formation (Austin, 2000). In combination, hypertriglyceridemia, small, dense 
LDL particles, and decreased HDL cholesterol concentrations characteristic of the ALP 
confer a 3-6 fold increase in CVD development (Griffin et al., 1994). There is substantial 
evidence which has shown that the consumption of fat is directly linked to an ALP and 
the risk of CVD development. 
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1.1 Dietary Fats and Cardiovascular Disease 
Dietary fats are known to be linked to the development of chronic diseases 
through the diet-induced regulation of lipid and lipoprotein metabolism. The ALP is a 
form of dyslipidemia commonly associated with obesity, Type II diabetes, insulin 
resistance and CVD (Khan eta!., 2002). More specifically, the quality of fat in the diet is 
as important as the quantity of fat consumed. The relationship between dietary fat and 
CVD is due mainly to its impact on the plasma lipid and lipoprotein profile. Saturated 
fats are detrimental to cardiovascular health as they increase LDL-cholesterol 
concentrations, promote the formation of atherosclerotic lesions, and the development of 
an ALP (Harris, 1989). Unsaturated fatty acids, on the other hand, namely 
monounsaturated (MUF A) and polyunsaturated (PUF A) fatty acids have been deemed 
cardioprotective due to their plasma lipid lowering capabilities and ability to improve an 
ALP (Harris, 1989). Thus, in recent years, a great deal of clinical and epidemiological 
research has been focused on the consequences of the enrichment of diets with MUF A 
and the essential PUF A, namely the omega-6 (n-6) and omega-3 (n-3) fatty acids. 
1.1.2 Monounsaturated Fatty Acids and the Plasma Lipid Profile 
Monounsaturated fatty acids are commonly found in the diet in the form of oleic 
acid (18:1). It was originally thought that supplementation ofMUFA in the diet exerted 
neutral effects on the plasma lipid and lipoprotein profile, and thus were not as 
favourable a fatty acid for the reduction of hypercholesterolemia (Keys eta!., 1965; 
Hegsted eta!., 1965). More recent studies however, have shown that there are favourable 
effects of MUF A on the plasma lipid profile when they are substituted for dietary 
3 
saturated fatty acids (SF A) (Mattson & Grundy, 1985; Katan et al., 1995). Much of the 
evidence for the beneficial effects of MUF A arises from studies of Mediterranean 
populations and the Mediterranean Diet. This population shows a low prevalence of CVD 
despite a dietary fat intake level of -35%, obtained from MUF A mainly in the form of 
olive oil (Willett et al., 1995). More recently, data from the Nurses Health Study also 
demonstrate that there are cardiovascular benefits attributed to high intakes of MUF A 
(Hu et a!., 1997). 
The beneficial effects of MUF A arise from their capability to decrease both total 
and LDL-cholesterol without the development ofhypertriglyceridemia at increasingly 
high concentrations (Mensink & Katan, 1992). It has been reported for example, that 
serum TG concentrations can decrease in normolipidemic or hypertriglyceridemic 
subjects on a high-MUFA diet (Mattson & Grundy, 1985; Grundy & Vega, 1988).This 
effect is reported to be independent of other dietary fatty acids, and occurs in a dose-
dependent manner (Yu et al., 1995; Gillet al., 2003). In a study by Couture et al. (2003), 
LDL-cholesterol concentrations in men were decreased by 16% relative to baseline 
measurements in subjects on a MUF A diet. Several studies in adults and children have 
provided further support for these findings (Wahrburg et al., 1992; Howard eta!., 1995; 
Kris-Etherton et al., 1999; Hodson et al., 2001; Nicklas et al., 2002; Rajarani et al., 
2002). In addition, the cholesterol-lowering properties ofMUFA have also been shown in 
children and adolescents with familial hypercholesterolemia (Guelesserian & Widhelm, 
2001). 
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1.1.3 Polyunsaturated Fatty Acids and the Plasma Lipid Profile 
The beneficial effects of PUF A are associated with both the n-6 and n-3 
subclasses. The n-6 and n-3 PUF A also differ however, in their effects on the plasma 
lipid and lipoprotein profile. Some of the earliest studies examining the influence of 
dietary fat on plasma lipids have shown that n-6 PUF A, namely linoleic acid, lower 
serum cholesterol concentrations. This effect is of particular notice when n-6 fatty acids 
are substituted for dietary saturated fat (Kinsell eta!., 1953). These results are supported 
by several investigators who have found a decrease in the LDL-cholesterol fraction upon 
supplementation with n-6 fatty acids (Vega eta!., 1982; Mattson & Grundy, 1985; 
Mensink & Katan, 1989; Katan et al., 1995). Omega-6 fatty acids have also been shown 
to reduce TG concentrations in hypertriglyceridemic patients (Grundy, 1975; Chart eta!., 
197 4 ). These results however, remain inconsistent. The effects of n-6 PUF A on the 
plasma lipid profile are primarily se~n in a positive light, however it has been shown that 
high intakes of these fatty acids may reduce HDL-cholesterol concentrations, which can 
be a potential threat to cardiovascular health (Vega eta!., 1982; Shepherd eta!., 1978, 
Jackson eta!., 1984). 
In contrast to the n-6 PUF A, n-3 PUF A have a distinct and consistent TG-
lowering effect (Harris, 1989). Supplementation of n-3 fatty acids. has been shown to 
decrease both VLDL assembly and apoB secretion (Harris, 1989; Wilkinson eta!., 1998; 
Kendrick & Higgins, 1999). Their effects on LDL-cholesterol concentrations however, 
remain inconsistent. In combination, and in appropriate proportions, n-6 and n-3 PUF A 
have the capability of significantly decreasing the risk of CVD development. 
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Consequently it is the ratio of n-6 and n-3 fatty acids that appears to be very important 
(Jump & Clarke, 1999). 
1.1.4 The Omega-6 to Omega-3 Fatty Acid Ratio 
Current diet trends in the Western world are more conducive to the development 
of chronic diseases such as CVD, Type II diabetes, and the associated hypertension and 
insulin resistance (Grimble, 1998). The Western population as a whole, particularly in 
North America does not benefit from the potentially anti-atherogenic properties of n-6 
and n-3 fatty acids due to extremely high fat consumption. The current n-6 to n-3 ratio (n-
6:n-3 ratio) peaks at 20-30:1 due mainly to an increase in the consumption of foods such 
as vegetable oil, which is increasingly rich in n-6 fatty acids (Simopoulus, 2002). This is 
a major concern as the n-6 and n-3 fatty acids compete for the elongase and desaturase 
enzymes required for breakdown and synthesis into eicosanoid products. Arachidonic 
acid is synthesized from n-6 fatty acids, and is the substrate for eicosanoids which play an 
important role in immune function, platelet aggregation, and cell proliferation. More 
specifically, n-6 derived eicosanoids, products of arachidonic acid, are potent inducers of 
platelet aggregation and inflammation (Simopoulos, 1999). It has been shown that 
enrichment of cells with arachidonic acid, particularly in red blood cells and platelets will 
increase the production of thromboxanes, prostaglandins and leukotrienes, and this can 
have deleterious effects on cardiovascular and respiratory health (Weber et al. 1989). In 
contrast to n-6 derived eicosanoids, those derived from n-3 fatty acids are considered to 
be anti-inflammatory and anti-aggregatory. Thus an excess ofn-6 fatty acids in the diet 
6 
may overpower the metabolism of n-3 fatty acids and promote an inflammatory, as 
opposed to an anti-inflammatory responsive system. 
There is international consensus that the current n-6:n-3 ratio of 20-30:1 needs to 
be lowered (Simopoulus, 2002). Current recommendations from the World Health 
Organization are to maintain an n-6:n-3 ratio of 5:1 to 10:1. The Canadian Government 
recommends 4:1 to 10:1. The optimal ratio remains controversial, with some 
recommendations as low as 2:1, or an equal amount ofboth n-6 and n-3 fatty acids 
(Simopoulos, 2002). The importance of decreasing the n-6:n-3 ratio for the improvement 
of cardiovascular health was demonstrated in the Lyon Heart Study (de Lorgeril eta!., 
1994). This dietary intervention study provided its subjects with a linoleic to alpha-
linolenic acid ratio of 4:1. At the end of a two-year period on this diet, they found an 
astounding 70% decrease in total mortality (de Lorgeril et al., 1994 ). It has also been 
shown that lowering the n-6:n-3 ratio from 20:1 to 6:1 was associated with a decrease in 
the prevalence of Type 2 diabetes in Indian populations (Raheja eta!., 1993). 
Furthermore, it has been suggested that one of the mechanisms behind the positive 
influence of n-3 fatty acid supplementation is the reduction of the n-6:n-3 ratio and the 
subsequent decrease in arachidonic acid-derived eicosanoids within the body. 
1.1.5 Fish Oil and the Plasma Lipid and Lipoprotein Profile 
In focusing on decreasing the n-6:n-3 ratio, one of the main objectives is to 
increase the consumption of n-3 fatty acid containing products. One such product that has 
recently gained a lot of attention is fish oil. The advantageous effects of fish oil 
consumption are due to its relatively high concentrations of the marine derived n-3 fatty 
7 
acids eicosapentaenoic (EPA) and docosahexaenoic (DHA) acid (Kagawa eta/., 1982; 
Dyerberg, 1986; Drevon, 1992). Bang eta!. (1972) first recognized the importance of 
these fatty acids in 1972. These authors found that the decreased incidence of ischemic 
heart disease in Greenland Eskimos, despite relatively high dietary fat intake, was 
attributed to marine n-3 fatty acid intake. 
Daily supplementation with fish oil has been shown to substantially decrease the 
development ofCVD (Harris, 1997; Hu eta!., 2002). To date, the GISSI (GISSI 
Prevenzione Investigators, 1999) is the largest randomized controlled trial to examine the 
effects of the supplementation of 4g per day of EPA and DHA to patients who had 
previously experienced myocardial infarction. This study showed a significant 1 0-15% 
reduction in the cumulative rate of all-cause death and non-fatal myocardial infarction 
after a period of 3.5 years. There is further evidence that has shown an n-3 fatty acid 
dependent prevention of arrhythmias and sudden cardiac death (Jones, 2002; Lemaitre et 
a/., 2003). 
The mechanisms by which fish oil improves cardiovascular function are 
numerous and include decreases in platelet aggregation (He, 2002), improvement in 
endothelial function (Mori & Beilin, 2001, Carroll & Roth, 2002), and the upregulation 
of lipid oxidation and simultaneous down-regulation of lipid synthesis (Carroll & Roth, 
2002). Fish oil has also been shown to alter the plasma lipid and lipoprotein profile. Fish 
oil has been consistently shown to reduce TG concentrations in both normal and 
hypertriglyceridemic individuals (Phillipson eta!., 1985; Harris, 1989; Sirtori eta!., 
1997; Williams et a!., 1998). This is significant as elevated TG concentrations are 
considered to be an independent risk factor for the development of CVD (Braunwald et 
8 
a!., 2001 ). Fish oil supplementation not only decreases fasting TG concentrations, but 
postprandial plasma TG concentrations are especially susceptible to chronic n-3 fatty acid 
consumption (Sanders et al., 1997; Harris, 1988; Roche & Gibney, 1996). The reductions 
in plasma TG concentrations are mainly due to their influence on the synthesis and 
secretion of TO-rich lipoproteins. Decreased hepatic TG synthesis, TG secretion, and 
assembly of chylomicrons and VLDL are characteristic properties of fish oil (Nossen et 
a!., 1986; Nestel eta!., 1984; Wilkinson eta!., 1998). 
Although fish oil has been shown to decrease plasma TG concentrations, the 
recommendation of fish oil for use as an anti-atherogenic therapy is still controversial. 
The effects of fish oil on total plasma and LDL-cholesterol concentrations remain varied. 
There are reports that nonnolipidemic patients ingesting fish oil have reductions in LDL-
cholesterol concentrations. On the other hand, both nonnolipidemic and hyperlipidemic 
individuals ingesting fish oil have higher LDL-cholesterol concentrations (Illingworth et 
a!., 1984; Nester eta!, 1984; Sullivan et al, 1986; Hsu et al., 2000). Fish oil-induced 
elevations in plasma total- and LDL-cholesterol concentrations have been consistently 
reported in humans and are thought to be attributed to pre-existing dyslipidemia such as 
hypertriglyceride~ia and Type II diabetes (Radack eta!., 1990; Fanner et al., 2001 ). 
Since elevated total plasma- and LDL-cholesterol concentrations are independent risk 
factors for CVD, it is important to understand the regulation of cholesterol metabolism by 
fish oil. 
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1.2 Triglyceride-Rich Lipoprotein Metabolism and the Role of Dietary Fats 
1.2.1 Hypertriglyceridemia and the Postprandial Response 
Hypertriglyceridemia is indicative of abnormal postprandial lipemia and 
commonly accompanies the development ofType II diabetes and obesity. The presence 
of exaggerated plasma TG concentrations is also highly associated with CVD (Austin, 
1991 ). It is only recently however that hypertriglyceridemia has been implicated as an 
independent risk factor for the development of CVD (Gotto eta!., 1998; Brewer eta!., 
1999; Miller et al., 2000). A meta-analysis conducted in 1996 using 17 population based 
studies revealed that increased plasma TG concentrations were associated with a 
significant risk for the development of CVD, initiating the adoption of elevated TG 
concentrations as an independent risk factor (Hokanson & Austin, 1996). 
Hypertriglyceridemia mainly arises from alterations in postprandial lipid and lipoprotein 
metabolism, which affects the synthesis, secretion,·and clearance ofTG-rich lipoproteins, 
namely chylomicrons and VLDL. 
The postprandial state consists of the metabolic processes that occur after the 
ingestion, digestion, and absorption of a meal (Roche et al., 1999). Most individuals wilr 
spend approximately 12 hours of their day in this state. Typically, plasma TG 
concentrations will increase shortly after a meal is ingested, and will not return to post-
absorptive concentrations until several hours after the last meal of the day (Bergeron & 
Havel, 1995). Accumulating evidence indicates that dietary fat has a large influence on 
postprandial metabolism, which includes the aforementioned synthesis, secretion, and 
clearance of TG-rich lipoproteins. 
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Saturated fatty acids have been shown to prolong the accumulation of VLDL in 
the plasma during the postprandial period (Bergeron & Havel, 1995), significantly 
increasing the development of dyslipidemia. Monounsaturated fatty acids have proven to 
be a double-edged sword, with reports of little or no effect on postprandial metabolism 
compared to SF A (Roche eta/., 1992), or beneficial effects with the inhibition of 
hypertriglyceridemia upon supplementation (Mens ink & Katan, 1992). PUF A have 
proven to be a positive influence on postprandial metabolism where individuals 
consuming diets rich in SF A had higher concentrations of chylomicrons and decreased 
clearance rates than those individuals consuming diets rich in n-6 or n-3 PUF A 
(Weintraub et at., 1988; Demacker et al., 1991 ). Longer term studies running for 15 and 
16 weeks reveal that n-3 fatty acids are most effective at reducing postprandial TG 
concentrations (Agren et al., 1996; Roche & Gibney, 1996). 
While postprandial TG concentrations are important determinants for CVD risk, 
evidence also suggests that fasting TO-concentrations are also influenced by dietary fat 
intake and should be taken into consideration. Consumption of n-3 PUF A for example 
has been shown to exert a dose-dependent hypotriglyceridemic effect on fasting plasma 
TG concentrations (Sanders et a!., 1983; Blonk et al., 1990; Schmidt et al., 1990). 
1.3 The Synthesis and Secretion of Triglyceride-Rich Lipoproteins 
There are two main postprandial pathways by which TG-rich lipoproteins are 
metabolized. These include the exogenous pathway where chylomicrons are synthesized 
in enterocytes from dietary fat and cholesterol and act as a lipid shuttle between the gut 
and blood, with the liver as their final destination. The second is the endogenous 
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pathway, which involves the synthesis of hepatic VLDL from dietary TO returned to the 
liver by chylomicrons, and hepatically available TO. Both pathways involve lipoprotein 
formation from apoB and microsomal triglyceride transfer protein (MTTP), and can 
potentially be regulated by dietary fat. 
1.3.1 Apolipoprotein B and the Synthesis and Secretion of TG-rich Lipoproteins 
Apolipoprotein B is a key apoprotein involved in the synthesis of both' 
chylomicrons and VLDL. There are two forms of apoB that exist in mammals. ApoB 100 
is the full length protein, and is synthesized exclusively by human liver, while apoB48 is 
a truncated version of apoB 100 and is synthesized in the small intestine (Davidson, 
2000). Two major steps are considered to be involved in the synthesis of these TO-rich 
lipoproteins, which include the synthesis ofapoB and the presence ofMTTP (Hussain, 
2000; Cartwright & Higgins, 2001 ). The first step in TO-rich lipoprotein synthesis 
involves the translocation of apoB 100 and apoB48 through the endoplasmic reticulum 
membrane in hepatocytes and enterocytes respectively (Berriot-Varoqueaux eta!., 2000). 
The addition of lipid begins co-translationally with the formation of a small apoB-
containing lipoprotein particle. This process is crucial for the synthesis of TG-rich 
lipoproteins as apoB is an essential structural component of both VLDL and 
chylomicrons (Wang et al., 2003). 
There are several common mutations found in the human apoB gene that reveal 
its importance in lipoprotein metabolism. These are most often due to either an insertion 
or deletion at the signal peptide region (Vincent et al., 2002). Hypobetalipoproteinemia is 
a result of a defect in the secretion of apoB, resulting in low plasma concentrations of 
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apoB-containing lipoproteins (Vincent et al., 2002). Hypercholesterolemia is a result of 
defects in the binding and clearance of apoB-containing lipoproteins (Vincent et al., 
2002). Individuals carrying this mutation have highly elevated plasma LDL-cholesterol 
concentrations and are at an increased risk for the development of CVD (Vincent et al, 
2002). An excess of apoB-containing particles has been shown to be a main trigger in the 
atherogenic process (Genest et al, 1992; Lamarche et al, 1997; Wallidus & Jungner, 
2001). 
1.3.1.1 Dietary Fats and Apolipoprotein B 
The effects of SF A intake on apoB secretion parallel those seen in plasma lipid 
concentrations. Myristic, palmitic, and arachidic acids for example, are shown to 
significantly increase apoB secretion compared to controls, where arachidic acid has the 
most potent effect in HepG2 cells (Arrol et al., 2000). These authors also find that MUF A 
(oleic and palmitoleic acid) can significantly increase apoB secretion above control 
values. On the other hand, several studies have shown that diets rich in MUF A 
significantly reduce apoB concentrations (W ahrburg et al., 1991; Aro et al., 1998; Gill et 
al., 2003; Desroches et al., 2004). Kinetic studies examining VLDL apoB in 
hypercholesterolemic adults revealed that apoB concentrations were significantly reduced 
by increasing the MUF A content of the diet (Gill et al., 2003). Similar kinetic studies also 
report an effect of a high MUFA diet on VLDL apoB100 (Desroches et al., 2004). 
In comparison to MUF A, n-3 fatty acids, particularly those from fish oils, are 
known to decrease apoB secretion (Matsumoto et al., 1987). The hypotriglyceridemic 
effects of n-3 fatty acids mentioned in the previous section are mainly attributed to the 
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inhibition of VLDL synthesis and secretion. Omega-3 fatty acids are thought to exert 
these properties through an increase in intracellular apoB degradation (Wong et a/., 
1989). This has been supported by several studies in both HepG2, rat and hamster 
hepatocytes cell lines (Ribeiro et a!., 1991; Wang et a!., 1993; Brown et a!., 1997; 
Kendrick & Higgins, 1999; Fisher et al., 2001 ). In hamster hepatocytes for example, 
Kendrick and Higgins (1999) demonstrate that the primary site of apoB degradation by 
dietary fish oils is the endoplasmic reticulum. Studies by Wang eta!. (1993, 1994) also 
show that both EPA and DHA stimulate hepatic apoB degradation. This phenomenon 
also occurs in the intestine where apoB48 secretion is inhibited in hepatocyes isolated 
from rats fed EPA and DHA (Brown et al., 1999). 
In humans, the effects of n-3 fatty acids are not as consistent. In men with visceral 
obesity, fish oil supplementation was shown to significantly lower hepatic secretion of 
apoB by 29% compared to placebo (Chan eta!., 2003). Similar results have also been 
reported in hyperlipidemic patients given 1 g/day of n-3 fatty acids for 10 weeks (Shidfar 
et al., 2003). However, in hypertriglyceridemic patients with diabetes, apoB production 
was unresponsive to fish oil supplementation (Fisher eta!., 1998). Inconsistencies among 
studies are likely due to differences in study design which include the time and amount of 
supplementation and method of apoB measurement. Further work into this area is quite 
relevant as apoB has recently been identified as an independent predictor of the risk for 
heart disease (Lamarche et al., 1996). 
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1.3.2 Microsomal Triglyceride Transfer Protein (MTTP) and the Synthesis and 
Secretion of TG-rich Lipoproteins 
1.3.2.1 VLDL Synthesis and Secretion 
MTTP is located both hepatically and intestinally and transfers lipid from the 
endoplasmic reticulum membrane to apoB. The lipidation of nascent apoB is a critical 
step in the formation ofVLDL and is catalyzed by MTTP (Cartwright & Higgins, 2001). 
Additional TG is added in this step of VLDL assembly by fusion of apoB with preformed 
lipid droplets (Berriot-Varoqueaux et al., 2000). The exact mechanisms by which this 
occurs are not full understood, but several investigators have shown a physical interaction 
between apoB and MTTP (Hussain et al., 1997; Hussain et al., 1998; Wu et al., 1996; 
van Greevenbroek et al., 1998). This binding is an essential component ofVLDL 
assembly. Compounds that disrupt the binding of MTTP to apoB can result in the 
decrease of apoB secretion by 75-80% (Hussain et al., 1998; Bakillah et al., 2000). The 
involvement ofMTTP in VLDL synthesis indicates that it plays a critical role in 
regulating plasma lipoprotein metabolism. The importance of MTTP is observed in 
patients with abetalipoproteinemia, where mutations in MTTP result in defective lipid 
transfer activity and absence of apoB-containing lipoproteins in the plasma (Davidson & 
Shelness, 2000; Gordon & Jamil, 2000). 
1.3.2.2 Dietary Fats and VLDL Synthesis and Secretion 
It has been clearly shown that dietary fatty acid composition has an influence on 
VLDL synthesis, secretion, and MTTP activity (Salter et al., 1998). Diets rich in SF A 
15 
increase VLDL synthesis and result in prolonged accumulation of postprandial VLDL 
(Bergeron eta!., 1995). Monounsaturated fatty acids reportedly have a similar effect as 
SF A on TG synthesis, despite their beneficial effects on plasma lipoprotein 
concentrations. Several investigators have found that oleic acid can induce a higher rate 
of TG synthesis, and can activate MTTP activity more so than linoleic or palmitic acids 
(Field eta!., 1988; van Greevenbroek eta!., 1998). Similarly, in hamsters, Bennett eta!. 
(1995) have shown that increasing the amount of triolein in the diet produces a linear 
increase in hepatic MTTP mRNA concentrations. 
Fish oils are known to exert opposite effects on VLDL synthesis in comparison to 
SF A and MUF A. They have been shown to suppress endogenous VLDL secretion (Ikeda 
eta!., 2001; Harris, 1997; Bordin et al., 1998; Williams et al., 2004). Kinetic studies in 
humans have indicated that n-3 PUF A inhibit VLDL synthesis and secretion (Harris, 
1990). Similarly, feeding studies show that n-3 fatty acids reduce hepatic secretion ofTG, 
cholesterol, and apoB in VLDL (Ribiero et al., 1991; Brown et al., 1999). In animals, n-3 
PUF A have been shown to decrease TG synthesis through the inhibition of lipogenic 
enzymes such as 1 ,2-diacylglyceroltransferase (Rustan et a!., 1988, 1989). In rats fed 
diets with either 1 0% w/w fish oil or olive oil, those rats on the olive oil diet showed a 
higher rate ofTG and VLDL formation than those on the fish oil diet (Lottenberg et al., 
1992). Similarly, in hypertriglyceridemic men, Westphal et al. (2000) found that 
treatment with n-3 fatty acids reduced fasting VLDL-TG concentrations by 44% 
compared to other dietary fats. Fish oils have also been shown to decrease apoB 100 
secretion from HepG2 cells (Wong et a!., 1989). 
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While several investigators have demonstrated that dietary fat can alter MTTP 
activity, the effects of specific fatty acids have not been well studied. It has been shown 
in hamsters however, that the response of hepatic MTTP mRNA to dietary fat is dose-
dependent (Bennett et al., 1995). This group found that triolein, or a mixture of triolein 
and linoleic acid reduced hepatic MTTP mRNA levels compared to a mixture of triolein 
and SF A. The capability of fish oils to lower VLDL synthesis and secretion suggests that 
these n-3 PUFAs may also influence hepatic MTTP activity. However, fish oils are 
thought to primarily act on reducing the synthesis of apoB. Their role in regulating 
MTTP activity has not yet been examined. 
1.3.3.3 Chylomicron Synthesis and Secretion 
Dietary fat is absorbed in the intestine by enterocytes, and ultimately assembled 
into chylomicrons (Cooper eta!., 1997). The translocation of apoB through the 
endoplasmic reticulum in enterocytes and subsequent lipidation of this nascent particle by 
MTTP is as important and occurs in the same manner as VLDL synthesis (Hussain, 
2000). Since MTTP is located both hepatically and intestinally, it is obvious that MTTP 
is involved in the assembly of chylomicrons and plays an important role in fat absorption 
from the gut (Salter et al., 1998). 
1.3.3.4 Dietary Fats and Chylomicron Synthesis and Secretion 
The metabolism of chylomicrons is also influenced by dietary fat, although this 
phenomenon has not been as thoroughly studied as the effects of dietary fat on hepatic 
lipoproteins. In general, SF A are known to increase chylomicron synthesis, while PUF A 
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reduce postprandial chylomicron concentrations (Harris, 1997). One of the first 
observations regarding the influence of dietary fat on chylomicron metabolism was seen 
by Tso eta!. in 1984. This group found that palmitic acid stimulated the output of 
chylomicron-sized lipoproteins while linoleic acid led simply to the formation of fewer, 
larger chylomicron-sized particles. Field eta!. (1988) also found that oleic acid treatment 
ofCaCo-2 cells reduced the rate ofTG synthesis. This work was further supported by van 
Greevenboek eta!. (1996) who found that oleic acid had a much greater impact on the 
suppression of de novo TG synthesis than linoleic and palmitic acids. Increasing the 
amount of fat in the diet also influences chylomicron metabolism. For example, as the 
quantity of fat in the diet increases, the ability of rabbit enterocytes to produce and 
secrete apoB48, TG, and cholesterol esters (CE) also increases (Cartwright & Higgins, 
1999). It is interesting that the rate of chylomicron synthesis was least influenced by 
dietary fish oil. Omega-3 fatty acids found in fish oil have also been shown to lower TG 
synthesis and secretion from CaCo-2 cells (Murthy eta!., 1990). However, it can be 
argued that chylomicron and VLDL assembly are not similarly affected by fish oil, as 
there is no direct evidence to indicate an inhibitory effect of fish oil on chylomicron 
synthesis. It has been shown that fish oil does not slow TG absorption or chylomicron 
secretion in rats (Harris, 1997) or rabbit enterocytes (Cartwright & Higgins, 1999). 
It is thought that the influence of fatty acids on chylomicron metabolism may 
reflect differences in the activity of MTTP towards TG with specific fatty acid 
compositions. The effect of specific fatty acids on intestinal MTTP activity however, has 
not been thoroughly investigated. 
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1.4 Triglyceride-Rich Lipoprotein Clearance 
1.4.1 The Role of Lipoprotein Lipase 
Lipoprotein lipase (LPL) is one of the most critical enzymes involved in 
lipoprotein metabolism (Braun & Severson, 1992; Enerback & Gimble, 1993; Mead et 
al., 2002). LPL is located on the luminal surface of the endothelium, attached by highly 
charged heparin-sulfate proteoglycans. The function of LPL is to catalyze the hydrolysis 
of the TG-rich lipoproteins, chylomicrons and VLDL. LPL generates the release of free 
fatty acids in the form of monoacylglycerol and non-esterified fatty acids (Potts et a!., 
1991) for uptake by adipose tissue for storage, or by the muscle to be oxidized and used 
for the production of energy (Pentikainen et al., 2002). 
Interestingly, LPL is considered to be both a pro-atherogenic, and an anti-
atherogenic enzyme. More specifically, a macrophage that expresses LPL is pro-
atherogenic, whereas muscle and adipose tissue LPL is anti-atherogenic. The pro-
atherogenicity of LPL was originally proposed by Zilversmit in 1973. This hypothesis is 
based on the fact that LPL produces chylomicron remnants and LDL, the remnant 
products of chylomicrons and VLDL respectively. Both of these have been implicated in 
the development of atherosclerosis (Botham et al., 1997 Phillips et al., 1993; Karpe & 
Hultin, 1995). It has been shown for example, that chylomicron remnants may be taken 
up as efficiently as LDL by blood vessel walls and significantly contribute to 
atherosclerotic lesions (Shaikh et al., 1991; Mamo & Wheeler, 1994; Proctor & Mamo, 
1998; Grieve et al., 1998). 
19 
The majority of the LPL enzyme is located on muscle and adipose tissue, the 
major sites of synthesis of the enzyme, and plays a protective role in atherosclerosis, 
mainly through the clearance of circulating lipoproteins (Mead et al., 2002). The 
protective effect of LPL has been demonstrated by several investigators (Mead et al., 
2002). Hydrolysis of lipoproteins by LPL drives the lipoprotein profile in a non-
atherogenic direction by increasing HDL-cholesterol concentrations (Mead et a!., 1999, 
2002). Several clinical studies have also shown that there is a strong correlation between 
the development of CVD and a decrease in LPL activity (Kastalein et a/., 2000; 
Hitsumoto eta/., 2000). For example, Hitsumoto eta/. (2000) demonstrated that patients 
with coronary atherosclerosis had significantly lower pre-heparin serum LPL mass than 
healthy patients. Furthermore, as previously mentioned, the delayed clearance of 
chylomicron remnants from the blood, which is associated with a decrease in LPL 
activity, is thought to be associated with the possible development of atherosclerotic 
lesions (Mahley eta/., 1991; Groot eta/., 1991; Patsch eta/., 1992). The anti-atherogenic 
properties ofLPL are particularly evident in patients with Familial Chylomicronemia 
Syndrome (Merkel eta/., 2002). Here, individuals who are homozygous for LPL-
deficiency are found to develop early atherosclerosis (Benlian et al., 1996), with dramatic 
increases in TG concentrations above 11.3mmol/L, chylomicronemia, and decreases in 
HDL-cholesterol. Diminished LPL activity in adipose tissue has also been implicated in 
the development ofhypertriglyceridemia in obese individuals and those who have type II 
diabetes (Mead et al., 1999; Mamputer et al., 1997). Additional evidence for the anti-
atherogenic potential of LPL is apparent in studies that examine the overexpression of 
LPL (Shimada et al., 1996; Yagyu eta/., 1999). These investigators have shown 
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normalization of an atherogenic lipoprotein phenotype when LPL is overexpressed in 
LDL receptor and apolipoprotein E (apoE) knock-out mice. 
Lipoprotein lipase is regulated by a vast number of hormones such as insulin, 
glucocorticoids, and adrenaline (Braun & Severson, 1992; Enerback & Gimble, 1993). 
Adipose tissue LPL for example, is exclusively activated by the action of insulin during 
the fed state (Eckel eta/., 1995; Panarotto et al., 2002; Arasaradnan et al., 2002). In order 
for maximal activation ofLPL however, apolipoprotein CII (apoCII) is necessary (Mead 
eta/., 2002). This apoprotein is located on the surface of both chylomicrons and VLDL. 
Without the presence of apoCII, LPL exhibits a much lower activity both in vitro and in 
vivo (Cryer et al., 1981; Wang eta/., 1992). 
1.4.1.1 Dietary Fats and Lipoprotein Lipase 
LPL has also been shown to be regulated by dietary fat, however the effects of 
specific dietary fats on LPL activity are limited and much less established than the role of 
hormones. Upon comparison of diets rich in SF A or MUF A, Roche eta/. (1998) found 
that LPL was not significantly different between these two diets. In addition, when used 
as a placebo, olive oil treated subjects had lower LPL activity than those fed fish oil 
(Khan eta/., 2002). 
The majority .of studies have examined the effects of n-3 fatty acids and fish oil 
on LPL activity and shown highly inconsistent results (Park & Harris, 2003). Moreover, 
the regulation of pre- and post-heparin LPL by dietary fats also appears to be partially 
dependent on whether an individual is in the fed or fasted state. Studies using various 
animal models such as rats, chickens, and pigs have not shown any effect of fish oil on in 
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vitro post-heparin LPL (Harris, 1987; Daggy eta!., 1987; Huff eta{., 1993). Several in 
vitro human studies have also reported that n-3 fatty acids do not enhance post-heparin 
LPL activity (Harris, 1988; Weintraub et a!., 1988; Desager et al., 1989; Nozaki et a!., 
1991; Lovegrove et al., 1997). A recent study in 2003 by Park and Harris for example, 
examined the specific effects of EPA and DHA on LPL activity using a trace amount of 
radiolabelled lipid emulsion that tracks native chylomicrons. These investigators found 
that while EPA and DHA significantly increased pre-heparin LPL activity during the fed 
state, that both pre- and post-heparin LPL activity were unaffected in the fasted state. On 
the other hand however, fish oil has the capability of increasing LPL activity and thus 
contributing to the anti-atherogenic properties offish oil (Kasim-Karis et al., 1995; 
Harris, 1997; Khan et al., 2002). Harris (1997) demonstrated in rats that chylomicron 
lipids were cleared at a much faster rate when the animals were fed fish oil compared to 
control animals who were not fed fish oil. Similarly, there have been reports of increases 
in LPL activity in both adipose tissue (Anil et al., 1992; Benhizia et al., 1994; Yoshiba et 
al., 1999) and muscle (Herzberg & Rogerson, 1989) in rats fed diets rich in n-3 PUF A in 
comparison to those fed n-6 PUF A. 
The explanation for the varied response of LPL activity is currently unknown. 
The activity of LPL as measured in the above mentioned studies however, is not 
necessarily a direct indicator of in vivo hydrolysis of chylomicrons and VLDL. The 
composition of chylomicrons and VLDL may also affect the rate ofLPL mediated fatty 
acid release. Fish oil feeding to animals and humans for example results in chylomicrons 
that show decreased lipolysis by LPL (Botham et al., 1997; Levy & Herzberg, 1999). It 
has also been shown that VLDL and chylomicrons compete for LPL activity where 
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chylomicrons are preferentially hydrolysed by LPL (Potts et al., 1991; Karpe eta/., 
1995). In individuals with elevated VLDL concentrations, the clearance of chylomicrons 
is partially inhibited (Grundy et at., 1976; Goldberg & Merckel, 2001). Furthermore the 
LPL enzyme becomes saturated at VLDL concentrations above 5mmol/L, which will 
concurrently decrease both VLDL and chylomicron metabolism (Brunzwell et al., 1973 ). 
Thus the lipid profile of an individual may exert a large influence on LPL activity. It has 
also been postulated that specific dietary fatty acids may modify the regulation of LPL by 
insulin (Sadur et al., 1984). It is obvious then, that while LPL is key in regulating both 
the extent and duration of postprandial lipemia, its regulation by dietary fat is an area of 
interest and requires further investigation. 
1.4.2 The Role of the LDL-Receptor 
The LDL receptor (LDLr) is another key component in maintaining cholesterol 
homeostasis through the endocytosis of chylomicron remnants and LDL by the liver 
(Larsson et al., 2004). The clearance of cholesterol-rich chylomicron remnants and LDL 
particles is accomplished by receptor-mediated endocytosis, fusion ofLDL with 
lysosomes, and recycling of the LDLr to the hepatic cell surface. The ligand binding 
domain of the LDLr recognizes both apoBIOO and apoE (Brown et al., 1983; Russell et 
al., 1989). ApoE-containing lipoproteins however have higher affinity for the LDLr than 
apoB-contaning lipoproteins (Innerarity et al., 1978). This is thought to occur due to the 
multiple copies of apoE which can bind to several LDL receptors. 
The importance of the LDLr and its role in the clearance of cholesterol-rich 
lipoproteins is apparent in individuals with the dominantly inherited disorder familial 
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hypercholesterolemia (FH). Here, dysfunctions in the LDLr lead to an accumulation of 
cholesterol-rich LDL in the plasma (7.8-13mmol/L in heterozygotes, and 16-31mmol/L 
in homozygotes) (Takahashi et al., 2004). These individuals also develop premature 
atherosclerosis (Schuster et al., 2002). Furthermore, the widely-used LDLr-knockout 
mice display severe hypercholesterolemia and the onset of premature CVD. 
1.4.2.1 Dietary Fats and the LDL-Receptor 
The amount, expression, and activity of the LDLr is primarily regulated by 
cholesterol, as established by Brown and Goldstein. Cholesterol regulates the expression 
ofthe LDLr via the binding of sterol regulatory element binding proteins to sterol 
regulatory elements (SRE) (Sudhof et al., 1987). It has been shown that high intakes of 
cholesterol will simultaneously down-regulate the biosynthesis of the LDLr and increase 
the circulating pool ofLDL (Beynen et al., 1983; Russell et al., 1983). On the other hand, 
when there is a shortage of hepatic cholesterol, cells will respond by upregulating the 
transcription of the LDLr (Ma et al., 1986). Earlier studies propose that in vivo regulation 
of the LDLr is regulated by cholesterol flux only (Takagi et al., 1989). More recent 
studies however, have also demonstrated the regulation ofLDLr activity and mRNA 
abundance by dietary fatty acids (Kurushima et al., 1995; Mistad et al., 1996). 
The saturated fatty acids, lauric (12:0), myristic (14:0), and palmitic (16:0) have been 
shown by several investigators to decrease LDLr activity, protein, and mRNA abundance 
(Woollett et al., 1992, 1994; Kurushima et al., 1995; Mustad et al., 1996; Nicolosi et al., 
1997). The literature investigating the effects of unsaturated dietary fatty acids however, 
are much more controversial. 
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In cell culture, the presence of MUF A have been shown to significantly increase 
activity of the LDLr (Daumerie et al., 1992; Rumsey et al., 1995; Gillet a!., 2003). 
Studies in hamsters have also shown similar results (Kurushima et al., 1995). In contrast 
to these findings however, Berry et al. (1992) demonstrated that LDLr status was 
unchanged in the presence of MUF A in fresh monocytes. The majority of studies have 
shown that supplementation of n-3 fatty acids, particularly fish oils, will decrease hepatic 
LDLr activity and mRNA abundance. Supplementation offish oil in HepG2 cells and rat 
hepatocytes has been shown to down regulate the LDLr and inhibit LDLr-mediated 
uptake (Roach et al., 1987; Wong & Paul, 1987). Similarly, Lindsay et al. (1992) 
measured LDLr activity in HepG2 cells both before and after fish oil supplementation. 
These authors found a 20% decrease in LDLr mRNA abundance and a 60% decrease in 
LDLr activity after fish oil supplementation. A more recent study in HepG2 cells by Pal 
et al. (2002) also found that LDLr binding potential, activity, protein, and mRNA levels 
concurrently decreased as the degree of unsaturation increased, where EPA had the 
greatest depressive effect. 
This reported down-regulation of the LDLr by fish oil has also been investigated 
in several animal studies (Hayes et al., 1988; Spady et al., 1995). Fish oil feeding to 
miniature pigs has been shown to decrease LDLr activity (Huff eta!., 1993), while a 70% 
decrease in the amount ofLDLr was seen in rabbits fed fish oil compared to sunflower oil 
(Wilkinson et al., 1998). In contrast to these findings, there are that diets enriched with 
fish oil can enhance LDLr activity (Ventura et al., 1989). Ventura et al. (1989) for 
example, found that rat chow enriched with 20% fish oil significantly increased LDLr 
activity. 
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The mechanism by which dietary fatty acids regulate the LDLr is as equally 
controversial as their direct effects on LDLr mRNA abundance and LDLr activity. It has 
been suggested that fatty acids regulated LDLr in a similar fashion as cholesterol, as 
PUF A have been shown to mediate SREBP expression (Worgall et a/., 1998). These 
authors found that increasing unsaturation led to an increase in the suppression of SRE-
mediated gene expression of the LDLr. Others suggest that dietary fats exert their effects 
independently of cholesterol and do not influence SREBP expression (Field eta/., 2003). 
Another school of thought is that dietary fats regulate LDLr activity by affecting 
cholesterol ester and free cholesterol regulatory pools by influencing acyl-coenzyme-A 
acyl transferase (ACAT) activity, involved in the esterification of hepatic cholesterol 
(Spady eta/., 1993; Dietschy eta/., 1993; Yu-Poth eta/., 2004). Further investigation 
into the role of dietary fat in the regulation of the LDLr will give insight into the 
therapeutic potential of the upregulation of the LDLr and consequent decrease in plasma 
cholesterol concentrations. 
1.4.3 The Role of Apolipoprotein E 
Apolipoprotein E is indisputably the most important ligand for the clearance of 
TG-rich lipoproteins. ApoE is synthesized and secreted primarily by hepatocytes 
(Kolovou eta/., 2003), and is abundant in humans at levels of 5-8g/L (Hasty eta/., 1999). 
The main function of apoE is to serve as a ligand for hepatic cellular lipoprotein 
receptors, namely the LDLr , and subsequent uptake by the liver (Curtiss & Boisvert, 
2000). ApoE is the main determinant of chylomicron and VLDL concentrations in the 
general population (Ordovas & Mooser, 2002) and accounts for approximately 30-50% of 
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TO-rich lipoprotein clearance (Kril eta!., 1983; Tomiyasu eta!., 2001). ApoE also 
facilitates the interaction of TO-rich lipoproteins with LPL (Asset et al., 2001). 
ApoE is considered to be an anti-atherogenic apolipoprotein and plays a large role 
in plasma cholesterol homeostasis. More specifically, apoE promotes the reduction of 
plasma cholesterol concentrations (Shimano eta!., 1992; Nikoulin & Curtiss, 1998). This 
is most apparent in patients with a deficiency in apoE, also known as Type III 
hyperlipoproteinemia (Mahley et a!., 1988). These individuals experience an 
accumulation of plasma chylomicrons and VLDL, both of which are risk factors for the 
development of CVD (Mahley et a!., 1988). The importance of apoE has also been 
revealed in apoE knockout mice. These mice have extremely high levels of plasma 
cholesterol compared with wild type mice and can lose their resistance to cholesterol 
feeding (Plump eta!., 1992; Zhang eta!., 1992). These mice have plasma cholesterol 
concentrations greater than 52mmol/L and develop complex atherosclerotic lesions 
(Piekrahita et a!., 1992). Interestingly, the re-introduction of apoE in experimental 
animals by such methods as bone marrow transplantation (van Eck eta!., 1997) or 
transgenics (Shimano et al., 1992) has been shown to decrease plasma cholesterol 
concentrations. Transgenic mice overexpressing human apoE for example are known to 
be resistant to cholesterol feeding (Shimano et al., 1992). 
1.4.3.1 Dietary Fats and Apolipoprotein E 
The regulation of apoE concentrations by the diet is a relatively new area of 
investigation. While diet is considered to be the main environmental challenger of apoE 
concentrations, the effects of specific dietary fats, especially fish oil, are not well studied 
27 
(Ribalta eta/., 2003). A recent study in humans by Buckley et al. (2004) has shown a 
15% increase from a basal level of 30g/L in apoE concentrations in a fish oil fed group. 
In contrast however, it has been shown that meals rich in SF A show a non-significant 
tendency for high postprandial apoE concentrations (Mero et al., 1998). Similarly, a 
recent study conducted in adult men found that ingestion of a meal enriched with SF A 
markedly increased the apoE content of TG-rich lipoproteins compared to MUF A and 
PUFA enriched meals (Jackson et al., 2005). 
One explanation for the inconsistent findings with respect to the regulation of 
apoE by dietary fat is the existence of apoE isoforms which are known to influence the 
plasma lipid and lipoprotein profile. ApoE isoforms result from three alleles: s-2, s-3, and 
s-4, and determine not only the concentration and amount of apoE in the plasma (Larson 
et al., 2000), but the affinity of lipoproteins for the LDLr (Ribalta et al., 2003). It has 
been shown that the presence of apoE isoforms may account for up to 40% of the 
variation that is seen in circulating TG concentrations (Salah et a/., 1997). ApoE isoforms 
have a large influence on lipoprotein concentrations where individuals carrying the s-2 
isoform have lower plasma- and LDL-cholesterol, and higher HDL-cholesterol 
concentrations then s-3 carriers, but s-4 carriers have higher total and LDL-cholesterol 
and lower HDL-cholesterol than s-3 carriers (Ribalta eta/., 2003). It has also been shown 
that s-2 and s-4 carriers have higher plasma TG concentrations compared to s-3 carriers 
(Dallongeville et al., 1992). Variations in apoE isoforms are also associated with an 
increased risk of premature atherosclerosis (Srinivasan et al., 1999; Rubin et al., 2002). 
The effect of dietary fats on apoE in isoform carriers has been more commonly 
studied than in individuals with a normal apoE genotype (absence ofapoE isoforms). 
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Some studies have shovvn for example that SF A intake worsens the lipoprotein profile 
(Campos et al., 2001) and increases the postprandial response in ~-2 carriers (Weintraub 
eta!., 1987; Orth et al., 1996), but not in ~-4 carriers. Others have shown that there is no 
difference in the plasma lipid response to dietary interventions across apoE genotype 
(Friedlander eta!., 2000). While apoE is key in regulating lipoprotein levels in the 
plasma and uptake by peripheral tissues, there is a great deal of uncertainty concerning 
the regulation of apoE by dietary fats. 
1.5 The Hamster as an Animal Model for the Study of Lipid and Lipoprotein 
Metabolism 
The hamster is considered to be an ideal animal model for the examination of 
lipoprotein metabolism due to its similarities to human lipoprotein metabolism (Nistor et 
a!., 1987; Spady et al., 1998). Hamsters carry a significant proportion of their serum 
cholesterol in the LDL fraction, as do humans (Ohtani eta!., 1996). Hamsters also have 
plasma cholesterol ester transfer protein (CETP) activity as seen in humans (Ahnet al., 
1994), whereas rats and mice have virtually no plasma CETP activity (Ha & Barter, 
1982). Most importantly, the secretion ofTG-rich lipoproteins in hamsters is very similar 
to humans. Hamsters secrete apoB48 exclusively from the intestine, and apoB 100 
exclusively from the liver, whereas rats secrete both forms of apoB from the liver: It is 
also known that the level of hepatic cholesterol synthesis in hamsters is equivalent to 
humans (Spady & Dietschy, 1988; Woollett eta/., 1989), and that cholesterol metabolism 
is also partially regulated by the LDLr (Chen et al., 1996; Remillard et al., 2001). 
Hamsters also secrete bile that is relatively rich in cholesterol (Anderson et al., 1986). 
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In addition to similarities in the blood lipid and lipoprotein profiles, hamsters also 
respond to dietary fat and cholesterol in the same manner as humans (Sullivan et al., 
1993). For example, serum LDL cholesterol concentrations increase in response to 
cholesterol and saturated fat (Woollett eta!., 1992). It has been shown however, that not 
all hamster strains respond similarly to dietary fat (Dorfman et a!., 2001 ). Different 
breeding laboratories such as Biobreeders and Charles Rivers labs produce two different 
hamster strains (Trautwein et al., 1993). The GS hamster from Charles Rivers is an 
outbred strain, whereas the F 1B hamster from BioBreeders is an inbred strain. Compared 
toGS hamsters, F 1B hamsters have lower HDL concentrations, and a higher VLDL and 
LDL to HDL ratio (Trautwein et al., 1993). F 1B hamsters also develop atherosclerotic 
lesions at much lower concentrations of dietary cholesterol (Kowala et al., 1991 ). 
Hypercholesterolemia is much more easily induced in F1B than GS hamsters (Nicolosi et 
al., 1998). It is thought that the varied response to dietary fatty acids seen among hamster 
studies may reflect strain-specific differences. In any case, the hamster is a widespread 
and useful model for the examination of lipid and lipoprotein metabolism. 
1.6 Genetics, Dietary Fats and CVD 
It has long been established that genetics and family history play a significant part 
in the development of CVD. It is evident from the literature mentioned in the previous 
sections on polymorphisms in MTTP, LPL, apoB, apoE, the LDLr, and the variability in 
animal models, that heterogeneity in genetic background, and gene-nutrient interactions 
have a large influence on plasma lipid concentrations. 
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Some of the first studies to recognize the diversity in the plasma lipid profile were 
conducted by Ahren et al. (1957) who found marked heterogeneity among subjects in 
their plasma cholesterol response to dietary cholesterol intake. Furthermore, there are 
several theories which involve the existence of hypo- and hyper-responders to dietary fat 
intake (Jacobs et a!., 1981; Katan et al., 1986). Phenotypic diversity in several animal 
models has also been shown to result in varied response to dietary fat intake 
(Bhattacharyya et al,, 1987; Overturf et al., 1990). In humans, a study by Gylling et al. 
(1992) found that low baseline plasma LDL-cholesterol concentrations, apoE2 
phenotype, and reduced bile acid synthesis were correlated with a low response to dietary 
cholesterol intake. While the most extensively investigated loci involved in gene-nutrient 
interactions studies are apoE, apoA4, apoB, LPL, and CETP (Ordovas et al., 2002), there 
is an increasing amount of evidence that variation in intestinal cholesterol absorption, or 
hepatic cholesterol synthesis between individuals is responsible for the difference in 
response to dietary fat (Stein et al., 2002). Further investigation into gene-nutrient 
interaction and heterogeneity in genetic background will give great insight into potential 
dietary therapies that may be moulded to an individual rather than a population, and 
could greatly decrease the variability in response to dietary fat. 
1. 7 Justification for this study 
Fish oil has typically been shown to be beneficial for the plasma lipid profile by 
reducing TG concentrations, which are known to be an independent risk factor for the 
development ofCVD. The effects offish oil on plasma cholesterol concentrations 
however, remain controversial. Previous work in our lab investigated the effects of fish 
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oil on the regulation of plasma lipoproteins, particularly its effects on LDL-cholesterol 
concentrations, using the F1B hamster as an animal model (de Silva et al. 2004). In order 
to determine the mechanisms by which fish oil was altering cholesterol metabolism, these 
hamsters were fed a low fat (5% w/w) or a high fat (20% w/w) fish oil diet for a period of 
two weeks. Surprisingly, fish oil did not reduce TO concentrations, but induced severe 
hyperlipidemia in these hamsters and had a deleterious effect on the plasma lipid and 
lipoprotein profile. F 1B hamsters fed the fish oil diet had highly elevated plasma-, VLDL-
and LDL- cholesterol and TO concentrations and the presence of milky plasma. Thus the 
high level of n-3 fatty acids present in the fish oil diet were not effective in lowering 
plasma lipid levels. Fish oil-fed F 1B hamsters also had a decrease in LDLr mRNA 
expression, and a significant decrease in CETP activity. 
The highly elevated plasma-, VLDL-, and LDL-lipid concentrations, the presence 
of milky plasma, and the alterations in cholesterol metabolism suggest that fish oil is 
regulating either the synthesis and secretion, or the clearance oflipoproteins in FtB 
hamsters. Thus in this study, we investigated the mechanisms by which fish oil regulates 
lipoprotein metabolism in the unique F1B hamster. We compared the effect ofthree 
specific diets: a fish oil diet, a diet rich in monounsaturated fatty acids (MUF A), and a 
diet with an n-6:n-3 ratio of 5 (N6:N3), using F 1B and OS hamsters. These three diets are 
considered to be cardioprotective and allow us to determine if the fish oil-induced 
hyperlipidemia is specific to fish oil, or if other fatty acids have this same effect. In 
addition, the fish oil-induced increase in LDL-cholesterol concentrations, compared to 
that seen in humans, presents us with a unique animal model to investigate the 
mechanisms by which fish oil is regulating cholesterol metabolism. 
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We also compared the F 1 B hamster to the GS hamsters to determine if the 
response to fish oil was strain-specific. It is not known whether these two hamster strains 
respond similarly to dietary fish oil and this comparison is important to recognize 
whether genetic background plays an important role in diet-induced regulation of lipid 
and lipoprotein metabolism. It is well known that the development of CVD can be 
partially attributed to genetics, and we are aware that heterogeneity within genetic 
background in humans contributes to the varied response to dietary fatty acid 
supplementation. Therefore the location of polymorphisms between hamster strains 
would provide insight into diet-induced regulation of lipoprotein metabolism in humans. 
The objectives of this study then were to determine how fish oil regulates lipid 
and lipoprotein metabolism in FtB and GS hamsters, and if this metabolism is 
differentially regulated between animal strains. We investigated the role that fish oil 
plays in lipoprotein secretion by examining the activity ofMTTP, and the protein 
expression of apoB. We also examined fish oils effects on lipoprotein clearance by 
examining LPL, ApoE, and the LDLr. 
We found that fish oil feeding to F1B and GS hamsters induced hyperlipidemia 
compared to these hamsters on the MUF A and N6:N3 diets. In addition, this dyslipidemia 
was much more prominent in FtB than GS hamsters. We also find significant effects of 
diet and strain on several components involved in lipoprotein metabolism which include 
LPL activity, and the expression of apoB and apoE. The findings of our study highlight 
the importance of several factors in the regulation of lipoprotein metabolism such as n-
6:n-3 balance in the diet, the effects of dietary fat on the synthesis, secretion and 
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clearance ofTG-rich lipoproteins including LPL activity, apoB and apoE, and the role 
that genetic background may play in nutritional studies. 
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Chapter 2 
Methodology 
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2.1 Animals and Diets 
Male Bio F1B and Golden Syrian hamsters (7 weeks old) were obtained from 
BioBreeders Inc. (Maryland, USA) and Charles Rivers Labs (Kingston, NY, USA) 
respectively. The animals were kept on a chow diet for one week prior to feeding special 
diets. After this equilibration period, animals in each strain were divided into one of three 
groups (n = 6, F1B; n = 6, GS) and were fed one of three specified diets for a period of 
four weeks. These specified diets consisted of fat-free semi-purified diet (ICN 
Biomedicals, Ohio, USA} supplemented with 200g/kg (20% w/w) of either fish oil (FO) 
(Menhaden oil, Sigma- Aldrich, Ontario, Canada), high MUF A safflower oil obtained 
from a local supermarket (MUF A), or a diet designed to give the animals an n-6:n-3 fatty 
acid ratio of -5 (N6:N3) using fish oil, safflower oil and lard. Due to the presence of 
2.5g/kg cholesterol in the fish oil diet (as per Sigma Aldrich Menhaden Oil composition), 
cholesterol was added to the MUFA and N6:N3 diets in appropriate proportions. The 
diets were kept at -20°C and given daily ad libitum. The composition of the diets is given 
in Table 1. Food intake was measured daily and animal body weight was measured 
weekly. The animals were housed in individual cages in a single room. The room was lit 
from 0700 hrs to 1900 hrs with the temperature maintained at 21 °C and humidity at 35 ± 
5%. All procedures were approved by Memorial University's Institutional Animal Care 
Committee in accordance with the guidelines of the Canadian Council for Animal Care. 
After the four week feeding period, the animals were fasted for 14 hours prior to 
sacrifice. The hamsters were then anaesthetized with halothane. The livers were freeze-
clamped in liquid nitrogen and stored at -70°C until further use. The intestines were .also 
removed and snap-frozen in liquid nitrogen, and stored at -70°C until further use. 
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Table 1 
Diet composition for the fish oil (FO), monounsaturated fatty acid rich (MUF A) and 
N6:N3 diets*. 
Diet 
glkg FO MUFA N6:N3 
Casein 200 200 200 
DL-Methionine 3 3 3 
Sucrose 305 305 305 
Maize Starch 190 190 190 
Vitamin mix3 11 11 11 
Mineral mix3 40 40 40 
Fibre§ 50 50 50 
Fat 200 200 200 
Cholesterol 2.5 2.5 2.5 
* Semi-purified diet designed for a 200glkg fut level 
aSupplied in quantities adequate to meet nutritional requirements (National 
Research Council, 1995) 
§Supplied as Alphacel non-nutritive bulk (ICN Biomedicals, Aurora, OH, USA) 
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2.2 Gas-Liquid Chromatography 
Gas-liquid chromatography (GLC) analysis was conducted to determine the fatty 
acid composition of the fish oil, MUFA, and N6:N3 diets (Table 2). Lipids were 
extracted from the diets using chloroform-methanol (2: 1 ratio) as described previously 
(Y okode et a/. 1990). Lipids were then trans-methylated by adding 2mL of 6% sulphuric 
acid in methanol and heating at 65°C for three hours. Fatty acid-methyl esters were 
extracted from each sample by adding 1mL of deionized water and 1 mL of hexane. The 
top hexane layer was transferred to a clean, acid-washed tube and dried under nitrogen. 
The fatty acid methyl esters were dissolved in 1 Of!L of carbon disulfide. Approximately 
2f.l.L of sample was placed into a glass vial insert and placed in a crimp vial (VWR, 
Ontario, Canada). Samples were run for 40 minutes on an Omegawax x320 
(30m*0.32mm) column from Supelco (Sigma-Aldrich, Ontario, Canada) using a flame 
ionization detector (FID). The GLC parameters were set as follows: oven, 196°C; 
injector, 240°C; detector, 250°C. Fatty acids standards were used for quantification 
purposes. 
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Table 2 
Fatty acid composition for the fish oil (FO), monounsaturatedfatty acid rich (MUFA), 
and N6:N3 diets 
(% of total fatty acids)* 
Fatty Acid Diet 
FO MUFA N6:N3 
14:0 15 0.8 4 
16:0 17 15 23 
16:1 n-7 10.3 1.5 4.5 
18:0 7.0 9.1 7.8 
18:1 6.2 53 41 
18:2 n-6 1 18 12 
18:3 n-3 0.5 0.8 
20:4 n-6 6 1.6 4.5 
20:5 n-3 12 0.2 1 
22:5 n-3 7 0.3 
22:6 n-3 18 1.9 
SFA 39 24.9 34.8 
MUFA 16.5 54.5 45.5 
PUFA (n-6) 7 19.6 16.5 
PUFA (n-3) 37.5 1 3.2 
* Lipids were extracted from the diets and fatty acid composition was 
determined by GLC 
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2.3 FPLC Separation of Plasma 
Plasma samples were separated on a Superose 6 Chromatography column (HR 
10/30) (Amersham Biosciences, Quebec, Canada). Plasma samples obtained from F1B 
and GS hamsters on the fish oil, MUF A, and N6:N3 diets were diluted to 200!J.L with 
HPLC water and filtered into inserts using a 0.22 micron syringe filter (Amersham 
Biosciences, Quebec, Canada) before injecting into the HPLC. The HPLC program 
consisted of a run time of 60 minutes and an injection volume of 75!J.L using a solvent 
system consisting of a 0.9% sodium chloride solution with 1% sodium azide. The plasma 
lipoprotein cholesterol profile was determined by using a post-column online enzymatic 
assay reagent (Cholesterol Liquicolor Kit, Stanbio, Texas, USA). 16mL of reagent was 
diluted with 0.02% sodium azide in I OOmL of HPLC water and the flow rate for the 
cholesterol reagent was set at 0.1mL/minute (Cheema & Agellon, 1999). 
2.4 Plasma Separation and Lipid Analysis 
Fasting blood samples were collected by cardiac puncture into tubes containing 
EDT A. The plasma was then separated by centrifugation at 3000rpm for ten minutes and 
stored on ice at 4°C until further analysis. Plasma was allowed to sit overnight to allow 
chylomicrons to separate. Chylomicrons were then removed before lipoprotein 
separation. Individual lipoprotein fractions were isolated by sequential density gradient 
ultracentrifugation using a TL 1 00 fixed angle rotor. The lipoproteins were separated 
according to specific densities of <1.006, 1.006-1.060, and> 1.060 g/mL for VLDL, LDL 
(LDL + IDL), and HDL respectively (de Silva et al., 2004). This was done using 
solutions which contained increasing amounts ofNaCl for VLDL and LDL separation, or 
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NaBr for HDL separation. to adjust the density of the plasma. To isolate VLDL, plasma 
(0.5mL) was added to a NaCl solution (0.5mL) with a density of 1.0063 g/mL and 
centrifuged at 100,000 rpm at 16°C for 2.5 hours with an acceleration of 5 and a 
deceleration of7. VLDL was then carefully removed and stored on ice at 4°C. To isolate 
LDL, a further 0.5mL ofNaCl solution with a density of 1.12 g/mL was added to the 
remaining sample and mixed gently. The conditions for centrifugation for isolation of 
LDL remained the same as those for VLDL. After centrifugation, LDL was then carefully 
removed and stored on ice at 4°C. In order to isolate HDL, 0.5mL ofNaBr solution with 
a density of 1.361 g/mL was added to the remaining sample and mixed gently. The 
sample was then centrifuged for 3.5 hours at 100,000 rpm at 16°C with an acceleration of 
5 and a deceleration of7. These lipoprotein fractions were stored on ice at 4°C and all 
analyses were performed within one week of plasma collection. 
The plasma and isolated lipoproteins were analyzed for total cholesterol 
(Cholesterol Liquicolor Kit, Stanbio, Texas, USA), TG (mono- and diacylglycerol 
included) (Triglyceride Enzymatic Kit, Stanbio Labs, Texas, USA), and free cholesterol 
(FC) (Free cholesterol Enzymatic Kit, Wako Chemicals, Virginia, USA). Cholesterol 
ester concentrations were determined by subtracting free cholesterol concentrations from 
total cholesterol concentrations. 
2.5 Hepatic Lipid Profile 
Liver lipids were extracted using chloroform-methanol (2: 1 ratio) as previously 
described and resuspended in 1 OOJ.LL of isopropanol (Folch et al. 1957). The liver lipids 
were analyzed for total cholesterol (Cholesterol Liquicolor Kit, Stanbio, Texas, USA), 
41 
TG (Triglyceride Enzymatic Kit, Stanbio Labs, Texas, USA), and FC (Free Cholesterol 
Enzymatic Kit, Wako Chemicals, Virginia, USA). Cholesterol ester concentrations were 
determined by subtracting free cholesterol concentrations from total cholesterol 
concentrations. Standards were also suspended in isopropanol for consistency. 
2.6 Lipoprotein Lipase Assay 
The LPL assay involved several steps including the release of LPL, preparation of 
the apoCII source, and the LPL enzyme assay. This assay measures the amount of free 
fatty acids released into the plasma by LPL. The LPL assay was performed using 
previously published methods (Nilsson eta!. 1976; McAteer eta!. 2003). F1B and GS 
hamsters on the specified diets were anaesthetized using Somnatol. Lipoprotein lipase 
was released into the circulation by the direct injection of250f.lL of heparin (250U/kg) to 
the heart. Heparin was allowed to circulate throughout the body for 5 minutes to release 
LPL into the blood stream. The addition of heparin was sufficient to act as an anti-
coagulant, thus blood was then collected by cardiac puncture and centrifuged at 3000rpm 
for 15 minutes at 4°C to separate the plasma. The plasma was stored at -70°C for the LPL 
assay. 
For the apoCII source, blood was obtained from a control hamster and incubated 
at 3 TC for one hour. The serum was obtained by centrifugation of the blood at 1100 rpm 
for 20 minutes. The LPL enzyme was inactivated by heating at 56°C for one hour. Serum 
was stored at -20°C as the source of apoCII. 
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2.6.1 Preparation of the Stock Glycerol Emulsion 
Tri [9,10_3H] oleoyl glycerol (Amersham Biosciences, Quebec, Canada) was 
purified on a silica gel Whatman TLC plate using a hexane: diethyl ether: acetic acid 
(80:20: 1) solvent system. Triolein was used as a standard, and bands were visualized 
using an iodine chamber. Tri [ 9,1 0_3H] oleoyl glycerol was extracted from the silica gel 
and added to 2mL of choloroform:methanol (2: 1) in a clean glass vial and vortexed for 2 
minutes. An additional I mL of the chloroform:methanol mixture was added to rinse the 
vial and the contents were transferred to a new vial. 
Triolein ( 414mg) and phosphatidylcholine ( 40mg) were added to the vial 
containing the purified glycerol tri [9,10 3H] oleate and dried under nitrogen. Glycerol 
(30mL) was then added, and the mixture was sonicated (45 amplitude) for four minutes at 
one-minute intervals. The glycerol stock solution was stored at room temperature. 
2.6.2 Lipoprotein Lipase Assay 
For the LPL assay, an emulsion containing a 0.62M Tris-HCI solution with 5% 
BSA, pH 8.6, serum as a source of apoCII, and the glycerol stock emulsion in a ratio of 
1:0.5:1 was prepared. Plasma (25J.tL) and 50J.tL of either 3.55M NaCl (hepatic lipase) or 
0.15M NaCI (total lipase) were added to glass tubes and pre-incubated at 30°C in a 
shaking water bath for 30 minutes. In order to start the reaction, 60J.tL of the emulsion 
was added to each sample and incubated at 30°C in a shaking water bath for 60 minutes. 
The reaction was stopped by adding 1.625mL of a methanol:chloroform:heptane solution 
(1.45:1.23:1) and 0.525mL ofO.IM potassium carbonate-potassium borate buffer, pH 
10.5. Samples were vortexed for 30 seconds and centrifuged at 1100rpm for 10 minutes 
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at room temperature. After centrifugation, 0.5mL of the upper phase was added to a 
scintillation vial with 18mL of scintillant. Radioactivity was counted in a scintillation 
counter. 
2. 7 Microsomal Triglyceride Transfer Protein Activity 
MTTP activity was measured in liver and intestine samples from FtB and GS 
hamsters on the fish oil, MUF A,. and N6:N3 diets using a kit method (Roar Biomedicals, 
New York, USA). IOOmg of liver or intestinal samples were homogenized in lmL of 
homogenization buffer (1M Tris, pH 7.4, 5M NaCI, 0.5M EDTA, IOOmM 
phenylmethanesulfonylfluoride (PMSF)) using a Teflon homogenizer at 4°C. The 
homogenate was then sonicated for 5 seconds at 1 minute intervals for 3 repetitions to 
completely disrupt the cells. The homogenate was then centrifuged at 9g for 5 minutes at 
4°C, and the supernatant removed, aliquoted, and stored at -70°C. Protein concentration 
was determined using the Lowry protein assay (Lowry, 1951 ). Protein ( 150J.Lg), 5 J.LL of 
self-quenched donor, and 5J.LL of acceptor (reagents in the kit) were diluted to a final 
volume of260J.!L with MTTP buffer (de Silva, 2004 b). The samples were incubated at 
3 7°C for 2 hours in a shaking incubator. The fluorescence was read using a Spectramax 
Gemini Fluroescence spectrophotometer at an excitation wavelength of 465nm, and an 
emission wavelength of 535nm. This assay measures the MTTP-mediated transfer of 
lipid in a sample, the intestine and liver in this case. This transfer is determined by the 
increase in fluorescence intensity as the fluorescent lipid is removed from the self-
quenched donor (mentioned above) to the acceptor. MTTP activity is subsequently 
expressed as pmol oflipid transferred, per hour, per milligram of tissue (pmollhr/mg). 
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2.8 LDL receptor mRNA expression 
RT-PCR was used to determine LDLr mRNA abundance in liver samples from 
FtB and GS hamsters fed the fish oil, MUFA, and N6:N3 diets as per previously 
published methods in our·lab (de Silva et al., 2004). Total RNA from hamster livers was 
isolated using the FastPrep RNA kit Green, and the FastPrep FP120 instrument 
(Qbiogene, Carlsbad, CA). RNA samples were checked for integrity on a 1.5 % agarose 
gel using borate buffer. 
Complementary DNA was synthesized by reverse transcription from 2!J.g of total 
RNA using Superscript II reverse transcriptase and used as templates for in vitro DNA 
amplification. Both the LDL-receptor and ~-actin mRNA were amplified simultaneously 
in a multiplex system. The specific primers were as follows: hamster LDLr sense 5 '-
TCGGTGACAA-TGTCGCACCAAG-3', antisense 5'-
. GCTTCTGGTACACTGGTTGTC-3', hamster~ -actin sense 5'-
CATCGTACTCCTGCTTGCTG-3 ',antisense 5' -GCTACAGCTTCAC-CACCACA-3'. 
PCR was conducted in the Genius PCR machine from Roche. The following 
conditions were used: initial heating to 94°C, steady at 94°C for I minute, 2 minutes at 
55°C, and 72°C for 3 minutes. The total number of cycles was chosen to remain within 
the exponential phase of the reaction at 30 cycles. PCR products were stored at 4°C and 
resolved on a 10% acrylamide gel in TBE buffer (Figure 2.1 ). The bands were quantified 
using the Chemilmager 4400 gel documentation system. LDL receptor mRNA expression 
was normalized against ~ -actin mRNA expression and expressed as relative units. 
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Figure 2.1: RT-PCR of the LDL-receptor and P-actio. Total RNA was reverse 
transcribed and eDNA was amplified by PCR for LDL-receptor and ~-actin in a 
multiplex system as described in the materials and methods section. Lane 1 represents 
the amplification in the absence of reverse transcriptase, lane 2 and 3 represents the 
amplification ofhamster ~-actin and LDL-receptor in the presence of reverse 
transcriptase, and lane 4 shows the 1 OObp ladder. 
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2.9 Western Blot Analysis 
The Western blot analysis was conducted by the use of previously published 
methods to measure the protein expression of apoB and apoE in plasma samples from 
F 1 B and OS hamsters on the fish oil, MUF A, and N6:N3 diets (Burnette, 1981 ). 
2.9.1 TCA Precipitate 
TCA precipitation was performed to delipidate the plasma and to determine the 
amount of protein in each plasma sample. Plasma (5~L), deionized water (20~L) and 
50% TCA (25~L) were added to an eppendorftube. Samples were allowed to precipitate 
on ice for 1 0 minutes and were then centrifuged at 10 OOOgfor 10 minutes. 250~L of 
1 0% TCA was the added to each sample, and samples were again centrifuged at 10 OOOg 
for 5 minutes. The pellet was then resuspended in 1 O~L of 1M NaOH. Deionized water 
(80~L) was added to each sample to bring the final volume to lOO~L. The samples were 
assayed for protein concentrations using the Lowry Method. 
2.8.2 Western Blot Analysis for ApoB 
Plasma samples containing 60~g protein from F1B and OS hamsters fed various 
diets were run on a 6% SDS polyacrylamide gel (Calbiochem, California, USA). 25~L of 
a biotinylated protein ladder was used as a marker. The gel was run for 1 hour and 15 
minutes at 200V. The proteins and marker were transferred to a nitrocellulose membrane 
(Trans~blot transfer medium, pure nitrocellulose membrane, 0.2uM, Biorad, California, 
USA) for 1.5 hours at 1 OOV at 4 °C. The membrane was then blocked for 1.5 hours in 
TBS buffer containing 5% (w/v) non~ fat dried Carnation milk (local supermarket) and 
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probed overnight with goat polyclonal antibody agam~B 100 and apoB48 
(Goat polyclonal antibody against human apoB, cat.no. 178467, Calbiochem, California, 
USA). The primary antibody dilution was 1:1000 in TBS buffer containing 0.05% Tween 
20 (TBST). The membrane was rinsed the next day with TBST and bovine anti-goat IgG 
conjugated with horseradish peroxidase (1 :5000 dilution with TBST) was added as a 
secondary antibody (Santa Cruz, California, USA). During the secondary antibody 
incubation, 2.5!J.L ofHRP-conjugated Anti-biotin antibody (Calbiochem, California, 
USA) was added after one half hour to detect the biotinylated protein marker. After 
washing with TBST, reactions were detected using enhanced chemiluminescence reagent 
system (Santa Cruz, California, USA). 
2.8.3 Western Blot Analysis for ApoE 
Plasma samples containing 60!J.g protein from F 1 B and GS hamsters fed various 
diets were run on a 10% SDS polyacrylamide gel (Calbiochem, California, USA). 25!J.L 
of a biotinylated protein ladder was used as a marker. The gel was run for one hour and 
seven minutes at 200V. The proteins and marker were transferred to a nitrocellulose 
membrane (Trans-blot transfer medium, pure nitrocellulose membrane, 0.2uM, Biorad, 
California, USA) for 1.5 hours at 100V at 4°C. The membrane was then blocked for 1.5 
hours in TBS buffer containing 5% (w/v) non-fat dried Carnation milk (local 
supermarket) and probed overnight with rabbit polyclonal antibody against human apoE 
(Dako, Denmark) The primary antibody dilution was 1:2000 in TBST. The membrane 
was rinsed the next day with TBST. Anti-rabbit HRP-linked antibody was added (1 :5000 
dilution) as a secondary antibody (Calbiochem, California, USA). During the secondary 
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antibody incubation, 2.5 J.tL of HRP-conjugated anti-biotin antibody was added after one 
half hour incubation to detect the biotinylated protein marker (Calbiochem, California, 
USA). After washing with TBST, reactions were detected using an enhanced 
chemiluminescence reagent system (Santa Cruz, California, USA). 
2.9 Statistical Analysis 
The effect of diet type and animal strain were determined using 2-way ANOVA. 
A Newman-Keuls post-hoc test was used to test significant differences revealed by 
ANOV A. Values are group means (n = 6, F1B; n = 6, GS) unless otherwise stated, and 
standard error of the mean (SEM). Differences were considered statistically significant 
when P ::5 0.05. 
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Chapter 3 
Results 
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3.1 Food Intake and Body Weight 
There was a significant effect ofstrain on body weight. GS hamsters were 
significantly heavier than F 1 B hamsters initially, and this continued throughout the entire 
course of the study (Table 3). There was no effect of diet on body weight. There was no 
significant effect of diet or strain on food intake (Table 4). 
3.2 Plasma Lipid Profile 
Figure 3.1 depicts plasma samples collected after a 14-hour fast in F1B hamsters 
on the fish oil and MUF A diet. F 1 B hamsters on the fish oil diet only had milky plasma 
containing chylomicron-like particles. Milky plasma was not observed in GS hamsters on 
the fish oil, MUF A, or N6:N3 diet. Figures 3.2-3.5 show the plasma cholesterol, TG, FC, 
and CE concentrations from F 1 B and GS hamsters on all three specified diets. There is a 
marked effect of both diet and strain on all four lipid parameters. Two-way ANOVA 
analysis revealed a significant effect ofboth diet (P < 0.0001) and strain (P < 0.0001) on 
plasma cholesterol, TG, FC, and CE. Due to the presence of a significant D x S 
interaction (P < 0.0001), one-way ANOVA was also performed. 
F 1B hamsters on the fish oil diet had significantly higher plasma total cholesterol 
concentrations (P < 0.001) compared to F1B hamsters on the MUFA and N6:N3 diets 
(Figure 3.2). Similarly, fish oil fed GS hamsters had significantly higher plasma total 
cholesterol concentrations (P < 0.001) than GS hamsters on the MUF A and N6:N3 diets. 
While fish oil feeding significantly increased total plasma cholesterol concentrations in 
both hamster strains, fish oil fed F 1B hamsters had significantly higher concentrations (P 
< 0.001) than fish oil fed GS hamsters. Plasma cholesterol concentrations in FtB 
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Table 3 
Initial and 4 week weight (g) for F1B and GS hamsters on the fish oil (FO), monounsaturated fatty acid rich (MUFA) 
and N6:N3 diets 
Animal Diet Initial 
BodyWeight 
(g) 
F1B FO 99.3 ± 2.9 
MUFA 103 ± 2.6 
N6:N3 98.1 ± 2.5 
GS FO 121 ± 1.9 
MUFA 118± 1.7 
N6:N3 122 ± 2.1 
Values are means SEM, (n=6 for FIB, n=6 for GS) 
Groups were compared by two-way ANOVA, p:'S0.05 
D, S represent diet and strain respectively 
Statistical Analysis Body Statistical Analysis 
Weight after 
4 weeks 
( ) 
Interaction P-value Interaction P-value 
s p < 0.0001 Ill ± 3.4 s p < 0.0001 
118 ± 2.5 
109 ± 3.7 
s p < 0.0001 125 ± 2.5 s p < 0.0001 
126 ± 2.4 
130 ± 2.7 
Table 4 
Average food intake for F1B and Golden Syrian hamsters fed thefrsh oil (FO), MUFA or 
N6:N3 diets 
Animal Diet Food 
Intake 
(glday) 
FIB FO 5.30 ± 0.25 
MUFA 5.46 ± 0.30 
N6:N3 5.04 ± 0.34 
GS FO 5.69 ± 0.38 
MUFA 5.04 ± 0.19 
N6:N3 5.86 ± 0.30 
Values are means and SEM, (n=6 for Fl B, n=6 for GS) 
Groups were compared by two-way ANOVA, p<O.OS 
D, S represent diet and strain respectively 
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Statistical Analysis 
Interaction P-value 
s p = 0.06 
D p = 0.63 
DxS p = 0.18 
Figure 3.1: F1B hamsters fed the fish oil diet had milky plasma containing 
chylomicron-like particles. F1B hamsters were fed the monounsaturated fatty acid-rich 
(MUFA) or fish oil (FO) diet for four weeks. Blood was collected via cardiac puncture 
and separated by centrifugation at 3000rpm for ten minutes. 
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MUFA FO 
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Figure 3.2: Plasma total cholesterol concentrations in F1B (D) and Golden Syrian 
( ~ ) hamsters fed the fish oil (FO), monounsaturated fatty acid rich (MUF A) or N6:N3 
diet for a period of 4 weeks. Fasting plasma samples were collected and analyzed for total 
cholesterol as described in the materials and methods section. Values are means and SEM 
(n = 6 F1B; n = 6 GS) analyzed by two-way ANOVA and the Newman-Keuls post-hoc 
test. Values with unlike lower case letters are statistically significant. 
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Figure 3.3: Plasma triglyceride concentrations in F1B CO) and Golden Syrian ( ~) 
hamsters fed the fish oil (FO), monounsaturated fatty acid rich (MUF A) or N6:N3 diet 
for a period of 4 weeks. Fasting plasma samples were collected and analyzed for 
triglycerides as described in the materials and methods section. Values are means and 
SEM (n = 6 F 1 B; n = 6 GS) analyzed by two-way ANOV A and the Newman-Keuls post-
hoc test. Values with unlike lower case letters are statistically significant. 
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hamsters on the fish oil diet were 3 times that of fish oil fed GS hamsters. There was a 
trend for an increase in plasma cholesterol concentrations in F 1 B hamsters on the MUF A 
and N6:N3 diets compared toGS hamsters, however this increase did not reach statistical 
significance. There were no significant differences between the MUF A and N6:N3 diets 
on plasma cholesterol concentrations in F 18 or GS hamsters. 
Plasma TG concentrations display a similar trend to plasma cholesterol 
concentrations (Figure 3.3). Fasting plasma TG concentrations in fish oil fed F 18 
hamsters were markedly higher (P < 0.0001) than F1B hamsters fed the MUFA and 
N6:N3 diets. In contrast, there was no significant effect of fish oil feeding on total plasma 
TG concentrations in GS hamsters as compared to GS hamsters on the MUF A and N6:N3 
diets. Plasma TG concentrations in fish oil fed F 1 B hamsters were 5 times higher than 
fish oil fed GS hamsters (P < 0.0001). There was no significant difference between the 
MUFA and N6:N3 diets on plasma TG concentrations in either F1B or GS hamsters. 
Plasma FC (Figure 3.4) and CE (Figure 3.5) concentrations show a similar trend 
as the plasma cholesterol and TG concentrations. One-way ANOV A revealed 
significantly higher plasma FC concentrations in fish oil fed F 18 hamsters compared to 
the MUFA and N6:N3 diets (P < 0.001). Fish oil feeding toGS hamsters also increased 
plasma FC concentrations compared to the MUFA and N6:N3 diets (P < 0.01). Similar to 
plasma cholesterol and TG concentrations, fish oil fed F1B hamsters had significantly 
higher plasma Fe concentrations than GS hamsters (P < 0.001). There were no 
significant effects of MUF A or N6:N3 feeding on plasma FC concentrations in either F 18 
or GS hamsters. 
61 
Figure 3.4: Plasma free cholesterol concentrations in F tB ( 0) and Golden Syrian ( l?ll) 
hamsters fed the fish oil (FO), monounsaturated fatty acid rich (MUF A) or N6:N3 diet 
for a period of 4 weeks. Fasting plasma samples were collected and analyzed for free 
cholesterol as described in the materials and methods section. Values are means and SEM 
(n = 6 F 1 B; n = 6 GS) analyzed by two-way ANOV A and the Newman-Keuls post-hoc 
test. Values with unlike lower case letters are statistically significant. 
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Figure 3.5: Plasma cholesterol ester concentrations in F1B ( 0) and Golden Syrian 
( ~ ) hamsters fed the fish oil (FO), monounsaturated fatty acid rich (MUF A) or N6:N3 
diet for a period of 4 weeks. Fasting plasma samples were collected and analyzed for 
cholesterol esters as described in the materials and methods section. Values are means 
and SEM (n = 6 F 1B; n = 6 GS) analyzed by two-way ANOV A and the Newman-Keuls 
post-hoc test. Values with unlike lower case letters are statistically significant. 
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Analysis of plasma CE concentrations revealed that fish oil fed F 1B hamsters had 
significantly higher concentrations than F1B hamsters fed the MUFA or N6:N3 diets (P < 
0.001) (Figure 3.5). In contrast, fish oil feeding did not significantly increase CE 
concentrations in GS hamsters compared to the MUF A and N6:N3 diets (P > 0.05). There 
were also no significant effects of MUF A or N6:N3 feeding on plasma CE concentrations 
in F1B or GS hamsters. 
3.3 FPLC Profile 
Fasting plasma samples from both F1B and GS hamsters on all three diets were 
separated on a superose column via FPLC (Figure 3.6). While chylomicrons were 
separated before FPLC analysis, the VLDL fraction should be considered to be VLDL 
and chylomicrons as complete removal of chylomicrons from the sample was not 
possible. F1B hamsters fed the fish oil diet had a significant portion of their plasma 
cholesterol present in the VLDL fraction in comparison to those hamsters on the MUFA 
and N6:N3 diets (Figure 3.6A). Fish oil fed GS hamsters also had higher VLDL-
cholesterol compared toGS hamsters on the MUFA and N6:N3 diets (Figure 3.6B). This 
increase, was dramatically higher for FtB hamsters. Both FtB and GS hamsters on the 
MUFA and N6:N3 diets had a comparable amount of their plasma cholesterol in the 
VLDL, LDL, and HDL fractions. 
3.4 Plasma VLDL Profile 
Since the FPLC profile revealed dramatic differences in individual lipoprotein 
fractions between diet and hamster strain, plasma lipoprotein fractions were separated by 
ultra-centrifugation and analysed for cholesterol, TG, FC and CE concentrations. There 
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Figure 3.6: FPLC separation of fasted plasma samples from F tB (A) and Golden Syrian 
(B) hamsters fed the fish oil (solid line) (-) monounsaturated fatty acid-rich (MUFA) 
(dashed line)(---), and N6:N3 (dotted line)(···) diets. Plasma samples were pooled from 
three animals in each group, filtered and analyzed on a Superose column as described in 
the materials and methods section. 
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Figure 3.7: Plasma very-low-density lipoprotein (VLDL) cholesterol concentrations in 
F 1 B ( 0 ) and Golden Syrian hamsters ( ~ ) fed the fish oil (FO), monounsaturated fatty 
acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected and VLDL was separated by density gradient ultracentrifugation and analyzed 
for total cholesterol as described in the materials and methods section. Values are means 
and SEM (n = 6 F 1 B; n = 6 GS) analyzed by two-way ANOV A and the Newman-Keuls 
post-hoc test. There was a significant interaction between diet and strain. 
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Diet P<0.0001 
Strain P<0.0001 
N6:N3 
Figure 3.8: Plasma very-low-density lipoprotein (VLDL) triglyceride concentrations in 
F ,B (D) and Golden Syrian ( ~) hamsters fed the fish oil (FO), monounsaturated 
fatty acid rich (MUFA) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples 
were collected, VLDL was separated by density gradient ultracentrifugation, and 
analyzed for tirglycerides as described in the materials and methods section. Values are 
means and SEM (n = 6 F 1B; n = 6 OS) analyzed by two-way ANOV A and the Newman-
Keuls post-hoc test. There was a significant interaction between diet and strain. 
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Diet P=0.003 
Strain P=0.0015 
N6:N3 
Figure 3.9: Plasma very-low-density lipoprotein (VLDL) free cholesterol concentrations 
in FtB (0) and Golden Syrian(~) hamsters fed the fish oil (FO), monounsaturated 
fatty acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples 
were collected, VLDL was separated by density gradient ultracentrifugation, and 
analyzed for free cholesterol as described in the materials and methods section. Values 
are means and SEM (n = 6 F1B; n = 6 GS) analyzed by two-way ANOVA and the 
Newrnan-Keuls post-hoc test. There was a significant interaction between diet and strain. 
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Diet P<0.0001 
Strain P<0.0001 
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Figure 3.10: Plasma very-low-density lipoprotein (VLDL) cholesterol ester 
concentrations in F 1B ( D ) and Golden Syrian (~)hamsters fed the fish oil (FO), 
monounsaturated fatty acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting 
plasma samples were collected, VLDL was separated by density gradient 
ultracentrifugation, and analyzed for cholesterol esters as described in the materials and 
methods section. Values are means and SEM (n = 6 F1B; n = 6 GS) analyzed by two-way 
ANOV A and the Newman-Keuls post-hoc test. There was a significant interaction 
between diet and strain. 
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was a marked difference in VLDL lipid composition between F 1 B and OS hamsters 
(Figures 3. 7-3.1 0). VLDL-cholesterol,- TO, -FC, and -CE were all influenced by both 
diet (P < 0.0001, P = 0.0014, P < 0.0001, and P < 0.0001 respectively) and animal strain 
(P < 0.0001, P = 0.0003, P < 0.0001, and P < 0.0001 respectively) with a significant 
interaction between diet and strain for VLDL-cholesterol (P = 0.0007), -TO (P = 0.0015) 
and -FC concentrations (P < 0.0001). 
Fish oil feeding to F 1 B hamsters was associated with a dramatic increase in 
VLDL-cholesterol, - TO, -FC, and -CE concentrations in comparison to the MUF A and 
N6:N3 diets (figures 3.7-3.10 respectively). In OS hamsters however, fish oil feeding did 
not have as significant an impact on VLDL lipid parameters as was seen in F 1B hamsters. 
VLDL-cholesterol concentrations in fish oil fed F1B hamsters were twice those seen in 
fish oil fed OS hamsters, while the VLDL-TO concentrations in fish oil fed F1B hamsters 
were 25 times that of the OS hamsters. VLDL-FC and -CE concentrations in fish oil fed 
F1B hamsters are also elevated compared to OS hamsters on the fish oil diet. 
Due to the nature of the statistical analysis and the large influence of fish oil on 
VLDL lipids, the effects ofthe MUFA and N6:N3 diets on VLDL lipid parameters are 
not statistically significant. However, there does appear to be a trend for an increase in 
VLDL-cholesterol, -TO, -FC, and -CE in F1B and OS hamsters on the N6:N3 diet 
compared to both hamster strains on the MUF A diet. 
3.4.1 Plasma LDL Profile 
Figures 3.11-3.14 depict the LDL lipid profile for F1B and OS hamsters. LDL-
cholesterol, -TO, -FC, and -CE were all independently influenced by both diet (P = 
77 
0.0006, P < 0.0001, P < 0.000 I, and P = 0.001 respectively), and animal strain (P = 
0.0004, P = 0.0348, P = 0.0005, and P = 0.0003 respectively). Only LDL-TG however 
showed an interactive effect of diet and animal strain (P = 0.0 118). 
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Figure 3.11: Plasma low-density lipoprotein (LDL) cholesterol concentrations in FtB 
( 0 ) and Golden Syrian ( ~) hamsters fed the fish oil (FO), monounsaturated fatty 
acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected, LDL was separated by density gradient ultracentrifugation, and analyzed for 
total cholesterol as described in the materials and methods section. Values are means and 
SEM (n = 6 F 1B; n = 6 GS) analyzed by two-way ANOV A and the Newman-Keuls post-
hoc test. There was a significant interaction between diet and strain. 
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Diet P=O. 0006 
Strain P=0.0004 
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Figure 3.12: Plasma low-density lipoprotein (LDL) triglyceride concentrations in F1B 
( 0) and Golden Syrian ( ~) hamsters fed the fish oil (FO), monounsaturated fatty 
acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected, LDL was separated by density gradient ultracentrifugation, and analyzed for 
triglycerides as described in the materials and methods section. Values are means and 
SEM (n = 6 F1B; n = 6 GS) analyzed by two-way ANOVA and the Newman-Keuls post-
hoc test. There was a significant interaction between diet and strain. 
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Diet P<O. 0001 
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Figure 3.13: Plasma low-density lipoprotein (LDL) free cholesterol concentrations in 
F 1 B ( 0 ) and Golden Syrian ( ~ ) hamsters fed the fish oil (FO), monounsaturated fatty 
acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected, LDL was separated by density gradient ultracentrifugation, and analyzed for 
free cholesterol as described in the materials and methods section. Values are means and 
SEM (n = 6 F tB; n = 6 GS) analyzed by two-way ANOV A and the Newman-Keuls post-
hoc test. There was a significant interaction between diet and strain. 
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Diet P<O. 0001 
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Figure 3.14: Plasma low-density lipoprotein (LDL) cholesterol ester concentrations in 
F rB ( D ) and Golden Syrian ( ~ ) hamsters fed the fish oil (FO), monounsaturated fatty 
acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected, LDL was separated by density gradient ultracentrifugation, and analyzed for 
cholesterol esters as described in the materials and methods section. Values are means 
and SEM (n = 6 F1B; n = 6 GS) analyzed by two-way ANOVA and the Newman-Keuls 
post-hoc test. There was a significant interaction between diet and strain. 
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Diet P=0.0010 
Strain P=0.0003 
N6:N3 
Fish oil feeding was associated with an increase in LDL-cholesterol, -TG, and -FC 
concentrations in F 18 hamsters compared to the F 18 hamsters fed the MUF A or N6:N3 
diet. Fish oil-fed GS hamsters also had elevated levels of LDL-cholesterol, -TG, and -FC 
concentrations compared to those on the MUFA and N6:N3 diets. Comparison ofthe two 
strains shows that this increase was much more pronounced in F 1 B than GS hamsters. 
LDL-cholesterol and TG concentrations in fish oil fed F 18 hamsters were approximately 
two times higher than those seen in fish oil fed GS hamsters. 
Interestingly, F1B hamsters fed the N6:N3 diet show a trend toward an increase in 
LDL-cholesterol, and -CE concentrations compared to MUF A-fed hamsters. The LDL-
cholesterol and -CE concentrations in F1B hamsters on the N6:N3 diet were two-fold 
higher than F 1 B hamsters fed the MUF A diet. 
3.4.2 Plasma HDL profile 
Figures 3.15-3.18 depict the HDL-cholesterol, -TG, -FC, and -CE concentrations 
respectively in F1B and GS hamsters. Diet had a significant influence on HDL-TG (P = 
0.0035), -FC (P = 0.0102), and -CE (P = 0.0035) concentrations, while strain 
independently influenced HDL-cholesterol (P = 0.0163) and -FC (P = 0.0120) 
concentrations. The only interactive effect between diet and strain was observed for 
HDL-CE concentrations (P = 0.0129). 
There was no effect of diet on HDL-cholesterol concentrations in F 18 or GS 
hamsters. Fish oil feeding to F1B and GS hamsters however, largely influenced HDL-TG 
and -FC concentrations compared to the MUFA and N6:N3 diets. Fish oil-fed F1B 
hamsters had HDL-TG concentrations that were three times those seen in fish oil fed GS 
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Figure 3.15: Plasma high-density lipoprotein (HDL) cholesterol concentrations in F 1B 
CD ) and Golden Syrian (~)hamsters fed the fish oil (FO), monounsaturated fatty acid 
rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected, HDL was separated by density gradient ultracentrifugation, and analyzed for 
total cholesterol as described in the materials and methods section. Values are means and 
SEM (n = 6 F1B; n = 6 GS) analyzed by two-way ANOVA and the Newman-Keuls post-
hoc test. There was a significant interaction between diet and strain. 
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Figure 3.16: Plasma high-density lipoprotein (HDL) triglyceride concentrations in F1B 
( 0 ) and Golden Syrian ( ~) hamsters fed the fish oil (FO), monounsaturated fatty acid 
rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected, HDL was separated by density gradient ultracentrifugation, and analyzed for 
triglycerides as described in the materials and methods section. Values are means and 
SEM (n == 6 F1B; n = 6 GS) analyzed by two-way ANOVA and the Newman-Keuls post-
hoc test. There was a significant interaction between diet and strain. 
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Diet P=0.0035 
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Figure 3.17: Plasma high-density lipoprotein (HDL) free cholesterol concentrations in 
F 18 ( 0) and Golden Syrian ( l?ll) hamsters fed the fish oil (FO), monounsaturated fatty 
acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected, HDL was separated by density gradient ultracentrifugation, and analyzed for 
free cholesterol as described in the materials and methods section. Values are means and 
SEM (n = 6 F 18; n = 6 GS) analyzed by two-way ANOV A and the Newman-Keuls post-
hoc test. There was a significant interaction between diet and strain. 
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Figure 3.18: Plasma high-density lipoprotein (HDL) cholesterol ester concentrations in 
F tB ( 0) and Golden Syrian (~)hamsters fed the fish oil (FO), monounsaturated fatty 
acid rich (MUF A) or N6:N3 diet for a period of 4 weeks. Fasting plasma samples were 
collected, HDL was separated by density gradient ultracentrifugation, and analyzed for 
cholesterol esters as described in the materials and method section. Values are means and 
SEM (n = 6 F1B; n = 6 GS) analyzed by two-way ANOVA and the Newman-Keuls post-
hoc test. There was a significant interaction between diet and strain. 
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Diet P=0.0035 
Strain P=0.5383 
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hamsters. Fish oil feeding to F 1 B also raised HDL-FC concentrations compared to the 
MUFA and N6:N3 diets. Interestingly, F1B and GS hamsters on the fish oil diet had 
lower HDL-CE concentrations than MUFA and N6:N3 fed F1B and GS hamsters. 
This finding is in contrast to the results obtained for VLDL- and LDL-CE 
concentrations. Both HDL-cholesterol and -FC concentrations were also influenced by 
strain, where F,B hamsters had consistently elevated HDL-cholesterol and -FC 
concentrations compared to GS hamsters. 
Both F ,Band GS hamsters on the N6:N3 diet show a trend for an increase in 
HDL-TG concentrations compared to hamsters on the MUF A diet. This effect was not 
apparent however in HDL-FC or -CE concentrations. 
3.5 Hepatic Lipid Profile 
Hepatic lipid concentrations for F 1B and GS hamsters are given in Table 5. 
Hepatic total cholesterol, TG, and CE concentrations were significantly influenced by 
diet (P < 0.0001, P < 0.0001, P < 0.0001 respectively). Fish oil feeding to F1B and GS 
hamsters significantly elevated hepatic cholesterol, TG, and CE concentrations compared 
to F ,Band GS hamsters on the MUF A and N6:N3 diets. Hepatic FC concentrations were 
unaffected by hamster strain. The N6:N3 diet also elevated hepatic lipid concentrations in 
comparison to the MUF A diet. Liver total cholesterol and CE concentrations were 
approximately 1.5 times higher in F1B and GS hamsters on the N6:N3 diet compared to 
the MUF A diet. Hepatic TG and FC concentrations remained similar in F 1B and GS 
hamsters on the MUFA and N6:N3 diets. 
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The hepatic TO concentration was the only parameter influenced by animal strain (P < 
0.0001 ). Hepatic TO concentrations in OS hamsters on the fish oil, MUF A, and N6:N3 
diets were two times higher than F1B hamsters on the fish oil, MUFA, and N6:N3 diets. 
3.6 Apolipoprotein B Protein Expression 
Figure 3.19 depicts representative plasma protein expression of apoB 1 00 and 
apoB48 in F1B (A) and OS (B) hamsters on the fish oil (lane 1), MUFA (lane 2), and 
N6:N3 (lane 3) diets. F 1B hamsters on the fish oil diet had markedly higher plasma 
apoB100 protein expression than F1B hamsters on the MUFA and N6:N3 diet. ApoBlOO 
was undetectable in F 1 B hamsters fed the MUF A diet at a protein conceqtration of 60!J.g. 
Surprisingly, after a 14-hour fast, plasma apoB48 was detected in F1B hamsters on both 
the fish oil and N6:N3 diets. The expression of apoB48 in fish oil fed F1B hamsters, 
however, was much greater than those hamsters on the N6:N3 diet. Fish oil feeding to OS 
hamsters had a similar effect as seen in F 1 B hamsters. Both apoB 100 and apoB48 were 
detectable in fish oil fed OS hamsters. ApoB 100 was present in OS hamsters fed the 
MUF A and N6:N3 diets, but to a lesser extent than fish oil fed hamsters. ApoB48 was not 
detectable in the plasma of OS hamsters fed the MUF A or N6:N3 diets. 
The expression of apoB 100 and apoB48 differed greatly between hamster strains. 
Fish oil fed F 1 B hamsters had markedly higher plasma protein expression of both 
apoB 100 and apoB48 than OS hamsters on the fish oil diet. In addition, the presence of 
apoB48 as seen in F1B hamsters fed the N6:N3 diet was not apparent in OS hamsters on 
the N6:N3 diet. 
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Figure 3.19: Apolipoprotein B protein expression in FtB (A) and Golden Syrian (B) 
hamsters. Hamsters fed the fish oil, monounsaturated fatty-acid rich, and N6:N3 diets are 
represented in lanes 1, 2, and 3 respectively. Proteins were separated on a 6% 
polyacrylamide gel and transferred to a nitrocellulose membrane. Apolipoprotein B was 
detected by Western blotting as described in the materials and methods section. This 
figure is typical of all the samples analysed. 
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3. 7 Microsomal Triglyceride Transfer Protein Activity 
Figure 3.20 and figure 3.21 show the intestinal and hepatic MTTP activity 
respectively for F1B and GS hamsters on all three diets. There was no significant effect of 
diet (P = 0.15) or strain (P = 0. 77) on hepatic MTTP activity. Similarly, there was no 
significant effect of diet (P = 0.74) or strain (P = 0.31) on intestinal MTTP activity. 
3.8 Lipoprotein Lipase Activity 
Figure 3.22 depicts the post-heparin lipoprotein lipase activity in F 1B and GS 
hamsters on the fish oil, MUF A, and N6:N3 diets. There was a significant effect of strain 
(P < 0.001) on lipoprotein lipase activity, however there was no significant effect of 
either the fish oil, MUF A, or N6:N3 diet (P = 0.26). F 1B hamsters had markedly lower 
post-heparin lipoprotein lipase activity compared to GS hamsters on all three diets. While 
there was no significant effect of diet on post-heparin lipoprotein lipase activity, there is a 
trend for a decrease in LPL activity in F1B hamsters fed the fish oil and N6:N3 diets. 
3.9 Hepatic LDL-Receptor mRNA Expression 
Figure 3.23 shows the hepatic LDL receptor mRNA expression in FIB and GS 
hamsters on all three diets. LDLr mRNA was normalized against hamster ~-actin and 
expressed as relative units. There was no significant effect of either diet (P = 0.1 0) or 
strain (P = 0.1676) on LDLr mRNA expression. 
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Figure 3.20: Intestinal microsomal triglyceride transfer protein (MTTP) activity in F 1 B 
(D) and Golden Syrian(~) hamsters fed fish oil (FO), monounsaturated fatty acid 
rich (MUF A) or N6:N3 diets. Animals were fed the specified diets for four weeks. Upon 
sacrifice, the intestines were removed and snap frozen in liquid nitrogen and stored at -
70°C. Tissues were then analyzed for MTTP activity as described in the materials and 
methods section. Values are means and SEM (n = 6 F1B; n = 6 GS) analyzed by two-way 
ANOV A and the Newman-Keuls post-hoc test. 
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Figure 3.21: Hepatic microsomal triglyceride transfer protein (MTTP) activity in F1B 
( 0) and Golden Syrian (~)hamsters fed fish oil (FO), monounsaturated fatty acid 
rich (MUF A) or N6:N3 diets. Animals were fed the specified diets for four weeks. Upon 
sacrifice, the livers were removed and snap frozen in liquid nitrogen .and stored at -70°C. 
Tissues were then analyzed for MTTP activity as described in the materials and methods 
section. Values are means and SEM (n = 6 F1B; n = 6 GS) analyzed by two~way ANOVA 
and the Newman~Keuls post~hoc test. 
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Figure 3.22: Lipoprotein lipase activity in F 1B ( 0) and Golden Syrian (~)hamsters 
fed fish oil (FO), monounsaturated fatty acid rich (MUF A), and N6:N3 diets. The 
specified diets were fed for a period of four weeks. After a 14-hour fast, heparin was 
injected directly into the heart. Blood was collected and assayed for lipoprotein lipase 
activity as described in the materials and methods section. Values are means and SEM (n 
= 6 F 1 B; n = 6 GS) analyzed by two-way ANOV A and the Newman-Keuls post-hoc test. 
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Figure 3.23: LDL receptor mRNA expression in FIB (D) and Golden Syrian(~) 
hamsters. RT -PCR was performed on isolated hepatic RNA from both hamster strains on 
the fish oil, monounsaturated fatty acids rich (MUF A), and N6:N3 diets as described in 
the materials and methods section. LDLr mRNA expression was normalized to ~-actin 
and expressed as relative units. Values are means and SEM (n = 6 F 1B; n = 6 GS) 
analyzed by two-way ANOV A and the Newman-Keuls post-hoc test. 
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3.10 Plasma Apolipoprotein E Protein Expression 
Figure 3.24 depicts the plasma ApoE protein expression in F1B (A) and GS (B) 
hamsters on the fish oil (lane 2), MUF A (lane 3), and N6:N3 (lane 4) diets. All three diets 
had varying effects on plasma apoE protein expression in F1B and GS hamsters. F1B 
hamsters on the fish oil diet had markedly higher plasma apoE expression than F 1B 
hamsters on the MUFA and N6:N3 diets. In addition, MUFA fed F1B hamsters had the 
least expression of apoE. F 1B hamsters fed the N6:N3 diet had much higher expression of 
plasma apoE than those fed the MUF A diet. 
Fish oil-fed GS hamsters had markedly higher plasma apoE expression than GS 
hamsters on the MUF A and N6:N3 diets, similar to the findings for the F 1B hamsters. In 
contrast however, GS hamsters on the MUF A diet had an increase in apoE protein 
expression compared to those hamsters on the N6:N3 diet. 
There is an apparent difference in apoE expression between F 1B and GS hamsters 
on all three diets. F 1 B hamsters on the fish oil diet have an increase in apoE protein 
expression compared to fish oil fed GS hamsters. In addition, the effects of the MUF A 
and N6:N3 diets in F,B hamsters are reversed in GS hamsters. MUFA fed F1B hamsters 
show a decrease in apoE protein expression compared to MUF A fed GS hamsters, while 
F ,B hamsters on the N6:N3 diet have markedly higher apoE expression than GS hamsters 
on the N6:N3 diets. 
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Figure 3.24: Apolipoprotein E protein expression in the plasma ofF1B (A) and Golden 
Syrian (B) hamsters. The position of the molecular weight markers are indicated in lane 
1. Hamsters fed the fish oil, monounsaturated fatty acid rich, and N6:N3 diets are 
represented in lanes 2, 3, and 4 respectively. Plasma proteins were separated on a 10% 
SDS polyacrylamide gel and transferred to a nitrocellulose membrane. ApoE proteins 
were detected by Western blotting as described in the materials and methods section. This 
figure is typical of all (n = 8) samples analyzed. 
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Chapter 4: 
Discussion 
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4.1 Dietary Fats and CVD 
Many studies have shown that the quantity and quality of dietary fats can regulate 
lipid and lipoprotein metabolism, thus influencing the development of CVD. While SF A 
are known to promote hyperlipidemia and CVD development, PUF A, particularly the n-3 
fatty acids found in fish oil, are known to improve the plasma lipid profile and decrease 
the risk of CVD (Harris, 1989). Fish oil exerts its cardioprotective properties by 
suppressing plasma TG concentrations in a dose-dependent manner (Wong et al., 1984; 
Harris, 1989). There is however, a controversy that surrounds the recommendation of fish 
oil as an anti-atherogenic therapy. The effects offish oil on plasma and LDL-cholesterol 
concentrations are inconsistent. Several investigators have found that fish oil feeding to 
humans and animals can significantly raise plasma and LDL-cholesterol concentrations, 
which are a known risk factor for CVD (Dewailly, et al., 2001). 
Previous work in our lab has examined the regulation of lipid and lipoprotein 
metabolism by fish oil (de Silva et al., 2004). F1B hamsters were fed a fish oil diet for a 
period of two weeks. Surprisingly, these hamsters developed severe dyslipidemia with 
highly elevated plasma-, VLDL-, and LDL-cholesterol and TG concentrations, and the 
presence of milky plasma after a 14-hour fast. This unexpected response led us to believe 
that fish oil was affecting either the synthesis and secretion, or the clearance of TG- and 
cholesterol-rich lipoproteins. Thus in this study, we used three cardioprotective diets rich 
in either fish oil, MUFA, or containing an optimal n-6:n-3 ratio in FtB and GS hamsters. 
The use ofthese three diets allows us to compare the response ofF1B and GS hamsters to 
other dietary fatty acids to determine if the previously found dyslipidemia is specific to 
fish oil. In addition, the fish oil-induced elevation in LDL-cholesterol concentrations 
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previously observed in F 1 B hamsters affords a unique opportunity to examine the 
mechanisms by which fish oil may be increasing plasma cholesterol concentrations. 
There is a great deal of heterogeneity in genetic background amongst humans, 
which is partially responsible for the varied responses to dietary fatty acid 
supplementation. Therefore, in this study, the comparison of F 1B and GS hamsters 
allows us to determine if the response to fish oil is strain specific. The existence of 
polymorphisms between animal strain may be responsible for the fish oil induced 
hyperlipidemia in F 1 B hamsters, and may provide insight into the differential response to 
fatty acid supplementation in humans. 
4.1.1 Fish Oil and the Plasma Lipid Profile 
Fish oil is considered to be cardioprotective as it exerts beneficial effects on the 
plasma lipid profile by lowering plasma TG concentrations compared to other dietary 
fats. In this study however, fish oil feeding induced hyperlipidemia in both F1B and GS 
hamsters with elevations in plasma cholesterol, TG, FC, and CE concentrations compared 
to the MUFA and N6:N3 diets. F1B hamsters, in particular, had milky plasma after a 14-
hour fast when fed the fish oil diet, suggesting an inhibitory effect of fish oil on 
lipoprotein clearance. This study, and previously published work in our lab (de Silva et 
a/., 2004) are the first to demonstrate the hyperlipidemic effect of fish oil in F 1 B 
hamsters. The dyslipidemic effect of fish oil has however, been reported by other 
investigators in GS hamsters (Surette et al., 1992; Lin eta/., 1995; Kubow et al., 1996; 
Lu et al., 1996). GS hamsters receiving a diet with Menhaden oil and cholesterol for 27 
days for example, had significantly higher serum cholesterol and TG concentrations than 
hamsters on a safflower oil diet (Kubow eta/., 1996). Elevated TG concentrations have 
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also previously been reported in hamsters and New Zealand rabbits consuming diets 
containing fish oil (Hayes et al., 1992). Similarly, fish oil feeding to GS hamsters was 
shown to significantly increase plasma cholesterol concentrations in the presence of 
dietary cholesterol (Lin et al., 1995; Lu et al., 1996). Interestingly, in the absence of 
cholesterol, these authors found that fish oil supplementation decreased plasma 
cholesterol and TG concentrations. 
In humans, fish oil feeding has consistently been shown to reduce TG 
concentrations, primarily by reducing apoB and VLDL synthesis and secretion. There are 
several reports however, which have demonstrated that fish oil increases plasma 
cholesterol concentrations, mainly in the LDL fraction (Harris, 1989; Wilt et al., 1989). 
The hyperlipidemic effect of fish oil in this study, denoted by milky plasma in F 1 B 
hamsters and highly elevated plasma TG concentrations, may be attributed to an increase 
in the production ofTG-rich lipoproteins, or a reduction in their clearance. 
There are several factors related to the fatty acid composition of the fish oil diet 
which should be taken into consideration. The cholesterol content of the diet (0.25%) is 
relatively high. F 18 hamsters have been shown to respond to dietary cholesterol with 
large increases in plasma TG and cholesterol concentrations. Therefore, while all animals 
were given diets with the same cholesterol content, it is possible that the vast variations 
plasma lipid concentrations are due to the MUF A and N6:N3 diets reducing the impact of 
dietary cholesterol. In addition, the fish oil diet fed to these hamsters is low in n-6 PUF A, 
contributing to a lower N6:N3 ratio. This indicates that while a higher n-3 fatty acid 
concentration should be beneficial, it is apparently not in F 18 hamsters, and a balanced 
N6:N3 ratio is necessary to lower plasma cholesterol concentrations. In addition, a lower 
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n-6 fatty acid concentration may affect the hamsters response to SF A. It should also be 
noted that the C 14:0 to C 16:0 ratio is much higher in the fish oil diet than the MUF A and 
PUF A diets. It is known that 14:0 can elevate plasma cholesterol concentrations, while 
16:0 is generally considered to be a neutral fatty acid (Hayes, 1995). Therefore it is 
possible that the elevations in plasma lipid and lipoprotein cholesterol concentrations 
seen in F 1 B on the fish oil diet may be partially due to a higher level of SF A (particularly 
14:0) than the MUFA and N6:N3 diets. 
4.1.2 Monounsaturated Fatty Acids and the Plasma Lipid Profile 
The effects of a diet high in MUF A are mixed results in the scientific community. 
It was originally thought that supplementation of the diet with MUF A exerted neutral 
effects on the improvement of plasma lipids and lipoprotein profiles (Keys et al., 1965; 
Hegsted et al., 1965). It has been demonstrated however, that MUF A may possess 
cardioprotective properties that may equate those of PUF A (Gardner & Kraemer, 1995). 
Earlier studies in humans have shown favourable effects of MUF A on the plasma lipid 
profile when substituted for SF A (Mattson & Grundy, 1985; Katan eta!. 1995). More 
recent ~tudies, and certainly the evidence for the beneficial effects of the Mediterranean 
diet have provided a strong basis for supplementation of the diet with MUF A (Kris-
Etherton eta!., 1999; Hiraoka-Yamamoto et al., 2004). In our study both strains of 
hamsters on the MUF A diet had reduced total plasma cholesterol, TG, FC, and CE 
concentrations compared to those animals on the fish oil diet. This is consistent with the 
results of several other studies investigating the effects of MUF A supplementation on the 
lipid profile in hamsters (Sessions & Salter, 1994; Trautwein et al., 1999). In hamsters 
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fed a mid- or high-oleic oil diet, significant reductions in plasma cholesterol were noted 
compared to a high-linoleic oil diet (Nicolosi et al., 2002). Reduced plasma cholesterol 
concentrations were also reported in hamsters fed a diet rich in olive oil compared to 
those fed coconut oil (Mangiapane et al., 1999). In addition, several authors have also 
noted a significant decrease in the development of atherosclerotic lesions in GS hamsters 
on a MUF A diet (Mangiapane eta!., 1999; Nicolosi eta!., 2002). There are studies 
however, which have also demonstrated that MUF A and PUF A exert similar effects on 
plasma lipid and lipoprotein profiles. GS hamsters on both hypercholesterolemic PUF A 
and MUF A diets show no significant differences between plasma TG concentrations after 
a two-week feeding period (Nicolosi et al., 2002). It should be noted however, that the 
source of PUF A was not marine oil, but sunflower oil. This same study however, did 
demonstrate that GS hamsters on the MUF A diet developed atherosclerosis later 
compared to animals on the PUF A diet. 
4.1.3 The N6:N3 Ratio and Plasma Lipid Composition 
There is evidence that consumption of an optimal ratio of n-6 and n-3 fatty acids 
is valuable for maintaining a favourable lipid and lipoprotein profile (Jump & Clarke, 
1999). It is estimated that the current n-6:n-3 ratio in Western populations is 15-20:1, due 
mainly to an increase in the consumption of foods such as vegetable oils, which are 
increasingly rich in n-6 fatty acids (Simopoulos, 2002). An elevated n-6:n-3 ratio is 
potentially harmful as high concentrations of n-6 fatty acids within the body are thought 
to promote inflammation and platelet aggregation (Simopoulous, 1999). On the other 
hand providing an n-6:n-3 ratio of 4:1 has been shown to improve cardiovascular health 
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in humans (de Lorgeril eta/., 1994). There are very few studies however, on the effects 
of diets with specific n-6:n-3 ratios in both humans and animals. Since we previously 
found that fish oil induced hyperlipidemia in F1B hamsters, we examined whether ann-
6:n-3 ratio of 5 had the ability to lower plasma lipoprotein concentrations as opposed to 
fish oil alone. This n-6:n-3 ratio proved to be beneficial for the plasma lipid profile in 
both F 1B and GS hamsters compared to hamsters fed the fish oil diet where the total 
plasma cholesterol, TG, FC, and CE concentrations were significantly reduced on the 
N6:N3 diet. Interestingly, we also noted a trend for an increase in plasma total 
cholesterol, TG and CE concentrations in F 1B hamsters on the N6:N3 diet compared to 
those on the MUF A diet. This suggests that the presence of even a small amount of fish 
oil in the diet has potentially damaging effects on the plasma lipid profile in hamsters. 
This change in lipid profile is most notable in the increase in LDL-cholesterol seen in 
F 1 B hamsters on the fish oil diet and will de discussed in the next section. 
4.1.4 Dietary Fats and VLDL Lipid Composition 
Dietary fat has a significant effect on plasma VLDL-cholesterol,-TG, -FC, and-
CE concentrations where F 1B and GS hamsters on the fish oil diet had highly elevated 
VLDL-lipid concentrations compared to those hamsters on the MUFA and N6:N3 diet. 
While these results are consistent with previous findings in our lab (De Silva et al., 
2003), fish oil is not typically known to induce hyperlipidemia. In fact, the anti-
atherogenic properties associated with fish oil supplementation are due to its ability to 
decrease both plasma and VLDL-TG concentrations. Several studies conducted in 
hamsters however, have found that diets rich in fish oil and cholesterol increase VLDL-
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cholesterol concentrations, but have no effect on VLDL-TG concentrations (Surette et al., 
1992; Lin et al., 1995; Kubow eta!., 1996; Lu et al., 1996). In this study, we found that 
VLDL-TG concentrations were elevated in F1B and GS hamsters on the fish oil diet, 
suggesting that fish oil is decreasing the clearance of TG-rich lipoproteins. 
It has been suggested that MUF A exert similar effects on the plasma lipoprotein 
profile as the n-3 PUF A (Kris-Etherton et al., 1999). In this study however, VLDL-lipid 
concentrations were the lowest in F 1B and GS hamsters on the MUF A diet. These 
findings are consistent with Trautwein et al. (1999) who found that VLDL-TG 
concentrations, and the VLDLIHDL ratio were significantly decreased in hamsters on a 
MUF A diet. It should be noted however, that the beneficial effects of MUF A seen by 
these authors were compared to that of a diet rich in SF A. In contrast to our findings, 
when a diet rich in MUF A was compared to a diet rich in PUF A, MUF A had no effects 
on VLDL lipid concentrations in GS hamsters, whereas PUF A from sunflower oil 
reduced them (Sessions & Salter, 1994). 
We also found that there is a trend for an increase in VLDL-FC and -CE 
concentrations in hamsters on the N6:N3 diet compared to hamsters on the MUF A diet. 
Omega-6 fatty acids typically reduce lipoprotein-cholesterol concentrations (Wijendran 
& Hayes, 2004), and have been shown to exert a greater plasma lipid lowering effect than 
MUFA (Kris-Etherton eta!., 2004). Therefore, the slight increase in VLDL lipid 
concentrations observed in hamsters fed the N6:N3 diet is likely due to the addition of 
fish oil, which has been shown in this study to drastically elevate plasma lipid and 
lipoprotein parameters. 
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The findings from this study on the effects of dietary fat on VLDL lipid 
concentrations are puzzling. Given that fish oils are known to possess 
hypotriglyceridemic properties and decrease VLDL synthesis and secretion in hamsters, 
it is likely that elevated VLDL-lipid concentrations are a consequence of inhibited 
hepatic uptake, and not the enhanced synthesis ofVLDL. 
4.1.5 Dietary Fats and LDL Lipid Composition 
The composition of the LDL particle is considered to be a strong-predictor of 
CVD development. There is a reported 1.5% decrease in CVD incidence for every I% 
reduction in LDL-cholesterol concentrations (Kris-Etherton et al., 1999). In this study, 
there was a significant effect of diet on LDL-cholesterol, -TG, -FC, and -CE 
concentrations. Fish oil appeared to significantly increase these lipid parameters, whereas 
the MUFA and N6:N3 diets lowered LDL lipid concentrations. We also note a small 
increase in all LDL-lipid parameters in hamsters in response to the N6:N3 diet. 
The controversy surrounding fish oil supplementation arises from its potentially 
harmful effects on LDL cholesterol concentrations. There is a growing body of evidence 
indicating that fish oil increases LDL-cholesterol concentrations in humans. Fish oil 
supplementation to hyperlipidemic and normolipidemic subjects has been shown to 
increase LDL-cholesterol concentrations (Sullivan eta!., 1986; Wilt eta!,, 1989; Kestin 
et al., 1990; Hsu eta!., 2000; Montori et al., 2000; Nestel et al., 2000; Dewailly et al., 
2001; Farmer et al., 2001 ). In addition, these increases in LDL-cholesterol have also been 
observed in hamsters (Surette et al., 1992; Lin et a/.,1995; Lu et al., 1996). In diets 
enriched with sardine oil, for example, a 90% increase in LDL cholesterol concentration 
was found in GS hamsters (Surette et al., 1992). Similarly, significant increases in LDL-
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cholesterol concentrations were observed in hamsters given n-3 fatty acids in comparison 
to both n-6 fatty acids, and diets rich in soybean oil (Lu eta/., 1996; Lin eta/., 1995). 
The mechanism behind this increase is unknown, and certainly puzzling considering the 
inhibitory effect of fish oil on VLDL secretion, and subsequent LDL production. It is 
thought that fish oils may increase the hydrolysis ofVLDL to LDL, or alter lipoprotein 
composition, which can affect binding affinity for LPL and the LDLr, which will be 
discussed in later sections. 
In addition, fish oil feeding to F 1B and GS hamsters significantly increased the 
TG content ofLDL. These findings are reminiscent of an ALP, where diet-induced 
hypertriglyceridemia results in the enrichment of LDL and HDL with TG, lipoprotein 
particles that normally carry cholesterol. Fish oil has typically been shown to reduce the 
development ofthis phenotype, thus a fish oil-induced increase in LDL-TG 
concentrations is not common. There are reports however, that fish oil increases TG 
concentrations in hamsters (Hayes et a/., 1992), although this was mainly observed in 
whole plasma as opposed to specific fractions. Researchers speculate that elevated lipid 
concentrations during fish oil supplementation may be attributed to elevated VLDL lipid 
concentrations (Lu et a/., 1996). 
In contrast to the effects of fish oil on LDL-lipid concentrations, hamsters on the 
MUF A diet had the lowest LDL-lipid concentrations. MUF A are typically thought to 
exert neutral effects on LDL-lipid levels. It has been argued that the effects of MUF A on 
LDL-lipid concentrations may not necessarily reflect the anti-atherogenic properties of 
MUF A, but rather the removal of other dietary fatty acids that are considered to be 
atherogenic. In this study however, we found that F 1B and GS hamsters on the MUF A 
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diet had markedly lower LDL-cholesterol, -TG, -FC, and -CE concentrations than those 
hamsters on the fish oil diet. Similarly, studies in GS hamsters have also shown 
significant decreases in LDL-cholesterol concentrations on diets enriched with olive oil 
compared to coconut oil, and sunflower oil (Sessions & Salter, 1994; Mangiapane et al., 
1999). In contrast to these findings however, comparison of a MUF A diet to a PUF A diet 
revealed no significant differences observed between LDL-lipid levels, furthering the 
hypothesis that MUF A have no effect on the plasma lipid profile (Nicolosi et al., 2000). 
Interestingly however, these authors found greater fatty streak formation in hamsters fed 
the PUF A diet compared to the MUF A diet. 
One of the most intriguing findings of our study is the effect of the N6:N3 diet. 
This diet was shown to increase LDL lipid concentrations compared to the MUF A diet, 
particularly in F 1 B hamsters. Omega-6 fatty acids, particularly linoleic acid, are 
considered to have the most potent LDL-cholesterollowering effects, at both high and 
low dietary intakes (Wijendran & Hayes, 2004). Thus in this study, the N6:N3 diet would 
ideally lower LDL-lipid parameters. Our results however provide further evidence that 
lipoprotein metabolism is altered when fish oil is added in the diet, and may be over-
powering the potentially positive effects of a balanced n-6:n-3 ratio. 
4.1.6 Dietary Fat and HDL Lipid Composition 
The composition and concentration of plasma-HDL is a strong predictor of the 
development of atherogenesis. An inverse relationship between the risk of CVD and 
HDL-cholesterol concentrations has been established (Kris-Etherton et al., 1999). Similar 
to VLDL and LDL particle composition, dietary fat intake plays a key role in HDL lipid 
123 
composition. In this study, there was a significant effect of diet on HDL-TO, -FC, and-
CE concentrations, but not on HDL-cholesterol concentrations. 
Fish oil feeding markedly increased HDL-TO and -FC, while HDL-CE 
concentrations were decreased in hamsters on the fish oil diet. The enrichment of HDL 
particles with TO is parallel to that seen in LDL particles during hypertriglyceridemia. 
HDL particles become susceptible to hydrolysis by hepatic lipase and the resultant HDL 
particle is small and deprived of cholesterol, resulting in a decrease in HDL-cholesterol 
concentrations, and subsequent increase in CVD risk (Austin, 2000). The enrichment of 
HDL-particles with TO during fish oil supplementation has not previously been reported 
in hamsters as the effects of fish oil on HDL composition are usually restricted to HDL-
cholesterol concentrations. 
The significant decrease in HDL-CE concentrations in fish oil fed hamsters 
compared to those on the other two diets is also an interesting finding and has been 
previously reported in our lab (De Silva et al., 2004). This decrease can be attributed to 
the fact that n-3 fatty acids have been shown to have less affinity for the hepatic LCA T 
enzyme (Parks et al., 1997, 1998). Poor esterification ofHDL-FC to HDL-CE by LCAT 
may account for the decline in HDL-CE concentrations. 
Our findings show no significant effect of diet on HDL-cholesterol 
concentrations. Similar studies in OS hamsters have shown that HDL-cholesterol 
concentrations are unaffected by fish oil supplementation (Kubow et al., 1996). There are 
other studies however, that demonstrate that fish oil significantly decreases HDL-
cholesterol concentrations (Ward & Clarkson, 1985; Surette et al., 1992; Lin et al., 1995; 
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Lu eta!., 1996). In humans. there are also reports of both increases and neutral effects of 
fish oil on HDL-cholesterol concentrations (Harris, 1988, 1996). 
The lowest HDL-TG and -FC concentrations in F 1 B and GS hamsters in this study 
were found on the MUF A diet. HDL-CE concentrations however were elevated, and 
there was no effect on HDL-cholesterol concentrations in the F tB or GS hamsters. In 
humans, dietary MUF A reportedly have no effect on HDL-cholesterol concentrations 
(Mattson & Grundy, 1985; Montoya et al., 2002; Nicklas et al., 2002). Similarly, HDL-
cholesterol concentrations in hamsters fed diets rich in olive oil or safflower oil remain 
unaffected compared to hamsters fed diets rich in SF A (Kubow et a!.; 1996; Mangiapane 
et al., 1999). In contrast however, MUF A diets were shown to significantly decrease the 
risk of atherogenesis by decreasing the VLDL:HDL ratio in GS hamsters (Trautwein et 
al, 1999). While diet does not affect HDL-cholesterol concentrations in this study, we do 
see a decrease in HDL-TG concentrations on the MUF A diet, shifting from an ALP on 
the fish oil diet to a more positive lipoprotein profile. The effects of MUF A on HDL-TG 
concentrations have not previously been reported in hamsters. In humans, however, 
MUF A have been shown to possess hypotriglyceridemic properties (Mensink & Katan, 
1992). 
The N6:N3 diet appeared to exert similar effects as the MUF A diet on HDL-FC, 
and -CE concentrations, with a lack of influence on HDL-cholesterol concentrations. 
These findings are consistent with the literature where n-6 fatty acids typically have 
negligible effects on HDL-cholesterol concentrations. There was however, an increase in 
HDL-TG concentrations in hamsters on the N6:N3 diet compared to those on the MUF A 
diet. These findings are consistent with the effects of the N6:N3 diet on VLDL- and 
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LDL-TG concentrations. It is obvious then, that the lipoprotein metabolism ofF 18 and 
GS hamsters is affected by the addition of fish oil in the N6:N3 diet. 
4.1.7 Comparison of Plasma Lipids in F1B and GS Hamsters 
It has long been established that heterogeneity in genetic background contributes 
to the varied plasma lipid in response to dietary fat intake (Ahren et al., 1957). Previously 
in our lab, we found that the F 18 hamster responded to a fish oil diet with severe 
dyslipidemia. In humans we also see a differential response to dietary fatty acid intake. 
Since the F 18 hamster is an inbred strain, we decided to compare this hamster to the 
out bred GS hamsters to determine if this unusual response to fish oil was strain-specific. 
Several investigators have reported that there are variations in plasma lipid 
concentrations between hamster strains (Kowala et al., 1991 ). Therefore, we 
hypothesized that F 18 and GS hamsters would respond differently to the fish oil, MUF A, 
and N6:N3 diets. We found that fish oil induced hyperlipidemia is much more 
pronounced in F 18 than GS hamsters. There was a significant effect of diet and strain on 
plasma cholesterol, TG, FC, and CE concentrations, where F18 hamsters on the fish oil 
diet had dramatically elevated concentrations compared toGS hamsters. In addition, F18 
hamsters on the fish oil diet had milky plasma packed with chylomicron-like particles 
which was not observed in fish oil fed GS hamsters. 
The possibility of heterogeneity in genetic background between hamster strains is 
well established (Kowala et al., 1991; Trautwein et al., 1993). While both F18 and GS 
hamsters have been shown to develop atherosclerosis on diets rich in fat and cholesterol, 
F 18 hamsters have been shown to be more susceptible to diet-induced atherosclerosis 
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than other hamster strains (Kowala et al., 1991). Dorfman et al. (2003) for instance, 
found that F 1 B hamsters have markedly higher total cholesterol concentrations than GS 
hamsters on diets rich in SF A. These authors also find significantly higher fasting plasma 
TG concentrations in F 1 B compared to GS hamsters. Further comparison of the F 1 B 
hamster to the DSNI hamster strain has also shown dissimilarities between strains where 
F 1 B hamsters had significantly elevated total cholesterol and TG concentrations, as well 
as increases in TG-rich lipoprotein cholesterol concentrations compared to DSNI 
hamsters (McAteer et al., 2003). 
The FPLC lipoprotein profile from this study also indicates that different 
responses to a high fat fish oil diet occur between the two hamster strains. Fish oil-fed 
F1B hamsters have a significant portion of their plasma cholesterol in the VLDL fraction 
compared to GS hamsters. We also find a significant effect of strain on VLDL, LDL, and 
HDL lipid concentrations. Differences in the lipoprotein profile are also reported in the 
literature where GS hamsters typically have increases in both LDL- and HDL-cholesterol 
in response to an atherogenic diet (Hayes eta!., 1992). F 18 hamsters on the other hand, 
have highly elevated LDL-cholesterol concentrations without appreciable effects on 
HDL-cholesterol, further suggesting genotypic differences between hamster strains 
(Kowalaetal., 1991). 
Dietary supplementation of both MUF A and PUF A to humans has a variety of 
effects on plasma lipid concentrations with either increases (Wilt et al., 1989; Kestin et 
al., 1990; Neste! et al., 2000; Dewailly et al., 2001) or decreases (Harper & Jacobson, 
2001 ). It is quite possible that differences within our genetic background contribute to 
this diverse response. The exact variation in genetic background responsible for the 
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reported response to dietary fat is unknown. but is likely attributable to numerous factors. 
The results from this study indicate a possible variation in the clearance of lipids from the 
plasma which include diversity in LPL activity. 
4.1.8 Dietary Fats and Hepatic Lipid Concentrations 
Dietary fat has a significant effect on hepatic total cholesterol TO, and CE 
concentrations, where fish oil feeding to both F 1B and OS hamsters significantly 
increased hepatic lipid concentrations. Similar results have been reported in our lab (de 
Silva eta/., 2004), and others (Gaiva eta/., 2003), where higher hepatic lipid 
concentrations have been observed in animals fed fish oil diets. The increase in hepatic 
cholesterol concentrations in fish oil fed hamsters also indicates an excess in cholesterol 
available for esterification, hence the increase in hepatic CE concentrations. Similarly, 
the decrease in hepatic cholesterol available for esterification in hamsters on the MUF A 
and N6:N3 diets accounts for the observed decrease in hepatic CE concentrations. These 
findings however oppose studies where MUF A have been shown to promote the storage 
of hepatic CE in hamsters (Sessions & Salter, 1994; Salter et al., 1998), resulting in 
elevated hepatic CE concentrations. 
The reason for the observed increase in hepatic lipid concentrations in fish oil fed 
hamsters cannot be explained. However, the development of hyperlipidemia and 
suspected decrease in lipoprotein clearance suggests that the increase in hepatic lipid 
content is due to enhanced hepatic lipogenesis rather than hepatic influx of dietary fat. 
Several hepatic enzymes such as ACAT, which is responsible for the hepatic 
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esterification of cholesterol, are known to be influenced by dietary fatty acid intake and 
availability and may be upregulated in these animals. 
In addition to the dietary effects on hepatic lipids, the difference in hamster strain 
in response to dietary fat is also apparent in hepatic TG concentrations. GS hamsters on 
all three diets had a 2-fold increase in hepatic TG concentrations compared to F 1B 
hamsters, while hepatic cholesterol, FC, and CE concentrations remain unaffected by 
hamster strain. The observed decrease in hepatic TG concentrations in F 1 B hamsters is 
expected due to the presence of milky plasma and highly elevated plasma lipid and 
lipoprotein TG concentrations. This suggests that despite elevated plasma and lipoprotein 
TG concentrations, the F 1B hamsters are neither storing, nor synthesizing an excess of 
hepatic TG. This further highlights the fact that elevated plasma cholesterol and TG 
concentrations are perhaps due to alterations in clearance of lipoproteins from the plasma 
and not the overproduction of hepatic-derived lipoproteins. 
4.2 Triglyceride-Rich Lipoprotein Metabolism 
4.2.1 Plasma Apolipoprotein B Protein Expression 
Apolipoprotein B is a key apoprotein involved in lipoprotein metabolism. In 
addition to its structural role in chylomicron, VLDL, and LDL formation, apoB48 and 
apoB 100 are required for the synthesis and secretion of chylomicrons and VLDL 
respectively. Due to the presence of milky plasma, and elevated plasma TG 
concentration, Western blot analysis was performed in this study using primary 
antibodies against human apoB to determine the origin of TG-rich lipoproteins. Both 
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apoB48 and apoB 100 were detected, indicating the presence of both intestinally and 
hepatically derived lipoproteins in F 1 B and GS hamsters after a 14-hour fast. 
We are the first to observe that F 1 B and GS hamsters on a fish oil diet had 
significantly higher plasma apoB48 and apoB 100 protein expression than hamsters on the 
MUF A and N6:N3 diets. Typically, n-3 fatty acids found in fish oil are known to 
decrease the synthesis and secretion of apoB by increasing the intracellular rate of apoB 
degradation (Kendrick & Higgins, 1999). There are reports however, with similar 
findings to our study where increases in apoB concentrations are observed upon 
supplementation of fish oil in HepG2 cells (Arrol eta!., 2000). 
In contrast to fish oil feeding, F 1B and GS hamsters on the MUF A diet had 
negligible amounts of apoB 100, and the absence of apoB48 protein expression. These 
findings are consistent with both human and animal studies where apoB concentrations 
are reduced by MUFA (Wahrburg eta!., 1992; Zambon eta!., 1995; Aro eta!., 1998; 
Desroches eta!., 2004). 
The supplementation of the N6:N3 diet produced very interesting changes in 
apoB 100 protein expression. The polyunsaturated n-6 fatty acids are known to 
significantly increase apoB expression, which is another aspect that contributes to the 
danger of elevated consumption of these fatty acids and an unbalanced n-6:n-3 ratio. 
Thus the decrease in apoB synthesis typically induced by n-3 fatty acids is necessary to 
prevent the oversecretion of apoB and its associated lipoproteins. In this study however, 
F1B hamsters on the N6:N3 diet had elevated apoB48 and apoBlOO protein expression, 
signifying an over-powering combination of fish oil and n-6 fatty acids on apoB protein 
expression. 
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In addition to dietary effects on apoB protein expression, the effect of hamster 
strain is also apparent. While apoB48 and apoB 100 protein expression were elevated in 
both F 1 B and GS hamsters on the fish oil diet, this effect was more obvious in F 1 B 
hamsters. Similarly, apoB48 and apoB 100 protein expression was elevated in F 1 B 
hamsters on the N6:N3 diet, but not in GS hamsters on the N6:N3 diet. The apoB 
concentrations in these hamsters parallel their differences in plasma lipid and lipoprotein 
concentrations as well, where F 1B hamsters had milky plasma, and significantly greater 
VLDL and LDL lipid concentrations than GS hamsters. We are the first to demonstrate 
variation in apoB protein expression between hamster strains in response to various 
dietary fats. These differences further highlight the heterogeneity between animal strains, 
and suggest differential regulation of lipoprotein metabolism by dietary fat in these 
animals. 
There are two plausible explanations for the variation in apoB protein expression. 
These include either the enhanced synthesis and secretion of apoB and apoB-containing 
lipoproteins, or a decrease in the clearance of these lipoproteins from the plasma. The 
latter of these two hypotheses is the most conceivable. The amount of apoB secreted by 
the intestine and liver is in excess of the requirement for the synthesis oflipoproteins. 
ApoB is quickly degraded when unused. Therefore, the presence of apoB48 in the plasma 
after a 14-hour fast is suggestive not of enhanced apoB48 synthesis, but of decreased 
catabolism. Furthermore, while fish oils are known to increase apoB concentrations, it 
was subsequently shown that hepatic TG accumulation was the dominant influence on 
this apoB secretion in human hepatocytes (Arrol eta/., 2000). It was previously 
mentioned that fish oil feeding to F 1B hamsters resulted in significantly less hepatic TG 
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accumulation than in GS hamsters, thus the availability of lipid substrates is an unlikely 
factor for the elevation in apoB protein expression. While the clearance of apoB-
containing lipoproteins appears to be the most likely explanation for the variation in apoB 
protein expression, the synthesis, secretion, and degradation of apoB were not measured 
in this study, therefore we cannot exclude the possibility that these aspects of apoB 
metabolism were influenced by dietary fat or animal strain. 
4.2.2 Dietary Fats and MTTP Activity 
The next step involved in the synthesis ofTG-rich lipoproteins involves the 
transfer of lipid to the newly synthesized, nascent, apoB particle for the formation, and 
subsequent secretion of intestinally derived chylomicrons, or hepatic VLDL, which is 
catalyzed by MTTP. The activity ofMTTP in this study was measured in both the 
intestine and the liver to determine if the substantial increase in chylomicron-like 
particles, VLDL, and apoB protein expression were due to an increase in their synthesis 
induced by fish oil. We hypothesized that fish oil feeding in F 1 B hamsters would increase 
MTTP activity to a greater extent than the MUF A and N6:N3 diets. This would allow us 
to partially attribute the increase in TO-rich lipoproteins, and apoB expression to 
enhanced MTTP activity. We found no effects of dietary fat or hamster strain on MTTP 
activity. 
The rate ofTG-rich lipoprotein secretion is strongly affected by the rate of 
endogenous production, which is particularly influenced by the availability of 
intracellular TG and fatty acids. The availability ofTG appears to be critical for the 
stimulatory effect of MTTP on chylomicrons and VLDL (Salter et al., 1998). We have 
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found however, that F1B hamsters on the fish oil diet in particular had significantly lower 
hepatic TG concentrations than GS hamsters. If we had found that dietary fat had an 
influence on MTTP activity, one would expect a decrease, rather than an increase in 
MTTP activity. 
Fatty acid availability, particularly the quality of fatty acid, is also known to affect 
MTTP activity (Salter et al., 1998). Studies on MTTP mRNA expression in hamster 
hepatocytes have shown that diets rich in SF A increase hepatic and intestinal MTTP 
mRNA expression (Lin et al., 1994; Bennett et al., 1995). Recently, it has also been 
shown that MTTP mRNA expression is unaffected by incubation with either n-3, or n-6 
enriched chylomicron remnants (Botham et al., 2003 ). These studies however, fail to 
mention if the effects on MTTP mRNA expression are correlated in any way with MTTP 
activity. 
The lack of effect of dietary fat or animal strain on both hepatic and intestinal 
MTTP activity, in addition to the abundance of evidence suggesting that fish oils 
decrease VLDL-secretion, further indicates that it is not the secretion ofTG-rich 
lipoproteins that is affected, but the clearance of these lipoproteins and their remnants 
from the plasma. 
4.2.3 Dietary Fats and Lipoprotein Lipase Activity 
The presence of apoB48 and apoB 100 and highly elevated plasma and VLDL-
cholesterol and -TG concentrations after a 14-hour fast in fish oil fed F1B hamsters 
indicates an inhibition in the clearance of TO-rich lipoproteins. Lipoprotein lipase is the 
rate-limiting determinant for the hydrolysis of chylomicrons and VLDL within the 
133 
plasma, and plays a key role in TO-rich lipoprotein clearance. In this study, there was a 
significant effect of strain, but not diet on post-heparin LPL activity. We found that F1B 
hamsters had significantly lower post-heparin LPL activity than OS hamsters indicating 
variations in genetic background between these two strains. This decrease in LPL activity 
in F 1 B hamsters provides a partial explanation for the severe hyperlipidemia seen in fish 
oil-fed F1B hamsters compared to OS hamsters. Similar results have been found in F1B 
hamsters, where this strain had significantly lower post-heparin LPL activity after 6 
months compared to DSNI hamsters (McAteer et al., 2003). This response however, was 
dependent on dietary cholesterol intake. 
In contrast to the effects of animal strain, post-heparin LPL activity was 
unaffected by the FO, MUFA, or N6:N3 diets used in this study. These findings are 
consistent with the majority of the literature in both humans and animal models which 
indicate that dietary fatty acids, specifically the n-3 fatty acids from fish oils, do not 
influence LPL activity, as LPL activity is mainly regulated by insulin concentrations 
(Park, 2003). It is in contrast however with studies by Kasim-Karis eta/. (1995), and 
Khan et al. (2002) who demonstrate that fish oils substantially increase post-heparin LPL 
activity. 
There are several possible explanations for both the results from this study, and 
the inconsistencies that exist in the literature. The measurement of LPL activity as 
determined by the post-heparin LPL assay is actually based on the amount ofLPL 
released from the tissue by the injection of heparin. Thus, this endogenous LPL activity 
does not necessarily reflect in vivo LPL activity or capability of chylomicron and VLDL 
hydrolysis. In addition, the LPL enzyme is known to be saturated at plasma TO 
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concentrations above 200mg/dL. Therefore, i~~G 
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concentrations reach levels upwards of 1900 mg/dL at the highest, and 350mg/dL at the 
lowest, the LPL enzyme is saturated and may not allow for reflection of the effects of 
dietary fatty acids. This may partially explain why we find only a trend for a decrease in 
LPL activity in fish oil-fed hamsters, as opposed to a significant outcome. 
In addition to the level ofLPL activity, dietary fatty acids are known to alter 
lipoprotein composition and the interaction of lipoproteins with LPL. While LPL activity 
may not be influenced by dietary fat, the amount and composition of lipoproteins may 
affect their affinity for LPL. Chylomicrons and VLDL for example, are known to 
compete for the LPL enzyme, where chylomicrons are preferentially hydrolysed (Griffin 
et al., 2001; Karpe & Hultin, 1995; Berr et al., 1992; Potts et al., 1991; Brunzell et al., 
1979). Therefore, in this study, the abundance ofTG-rich lipoproteins namely 
chylomicrons, as represented by the presence of apoB48 and apoB I 00, and VLDL as 
seen in the FPLC profile, might compete for LPL leading to a potential decrease in the 
hydrolysis ofboth chylomicrons and VLDL, and an increase in their circulating plasma 
concentrations. 
It is also known that the composition of the lipoprotein particle affects LPL-
mediated hydrolysis (Griffin, 2001). Lipoproteins which consist primarily ofn-3 fatty 
acids EPA and DHA for example, are thought to be smaller, TO-poor, and resistant to 
LPL-mediated hydrolysis (Botham et al., 1997; Levy & Herzberg, 1999; Oliveira et al., 
1997). Previous work in our lab has shown that F 1B hamsters on a fish oil diet have 
smaller VLDL particles compared to hamsters on a diet containing lard and safflower oil 
(de Silva, unpublished results). On the other hand however, it is thought that this 
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resistance is beneficial as there is less competition with chylomicrons for LPL and thus a 
reduction in postprandial lipemia (Griffin, 2001). The size oflipoprotein particles and 
their affinity for the LPL enzyme was beyond the scope of this study. It is quite possible, 
however, that changes in lipoprotein composition and size may affect their subsequent 
hydrolysis, regardless of LPL activity. This provides a possible explanation for the non-
significant decrease in LPL activity in fish oil fed hamsters. 
4.2.4 Dietary Fats and LDL Receptor mRNA Expression 
The LDLr is key in the removal and clearance of lipoprotein cholesterol from the 
plasma. It has been reported that the LDLr can also mediate the removal of chylomicron 
remnants (Faria et al., 1996). In this study, the effect of diet and strain on LDLr mRNA 
abundance was examined to determine if alterations in LDLr mRNA expression were 
partially responsible for elevated plasma lipid and lipoprotein concentrations. Dietary fats 
are known to regulate hepatic LDLr mRNA expression (Horton et al., 1993, 1994). In 
addition, LDLr mRNA expression has been shown to be negatively correlated with LDL-
cholesterol concentrations (Soutar et al., 1986; Nanjee et al., 1989; Wilkinson et al., 
1998). 
Both n-6 and n-3 polyunsaturated fatty acids have been shown to suppress LDLr 
mRNA abundance (Lindsey eta!., 1992; Surette et al., 1992; Wilkinson et al., 1998). 
These findings provide a link between the increases in plasma LDL-cholesterol 
concentrations that occur with dietary fish oil supplementation. In contrast, MUF A have 
been shown to increase LDLr mRNA expression in humans and hamsters (Daumerie et 
al., 1992; Kurushima et al., 1995; Rumsey et al., 1995; Gillet al., 2003). In this study 
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however, there was no significant effect of either diet or hamster strain on LDLr mRNA 
expression. 
The lack of influence of diet and animal strain on LDLr mRNA expression in this 
study does not exclude the possibility that LDLr activity or binding affinity are affected 
by these two endpoints. Dietary fatty acids have been shown to alter the LDLr protein, 
distribution rate, and recycling rate, none of which were examined in this study (Spady et 
a!., 1995). Alterations in any of these aspects by dietary fat or animal strain may account 
for the observed increases in plasma lipid and lipoprotein concentrations. In addition, the 
lipoprotein particle size is associated with the binding affinity of these particles to the 
LDLr (Nigon et al., 1991 ). Previous work in our lab has shown that fish oil-fed F 1 B 
hamsters have larger LDL particles than hamster on diets rich in lard and safflower oil 
(de Silva et al., 2004). Studies in fish oil fed subjects have also reported increases in LDL 
particle size (Sanchez-Muniz et al., 1999). In addition, it has been clearly shown that 
variation in lipoprotein particle size, especially very small or very large lipoprotein 
particles can decrease the affinity for the LDLr (Nigon et al., 1991 ). Therefore, in this 
study, modification of the fatty acid composition of lipoprotein particles, or alterations in 
the size of lipoprotein particles by either dietary fat or hamster strain may affect the 
binding of these particles to the LDL receptor, resulting in the observed hyperlipidemia. 
4.2.5 Dietary Fats and Apolipoprotein E Protein Expression 
A poE plays a critical role in the catabolism of the TG-rich chylomicrons and 
VLDL. The LDLr mediates TG-rich lipoprotein clearance as it has a high binding affinity 
for apoE (Faria et al., 1996). Plasma apoE protein expression was measured in this study 
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--------------to determine if dietary fat or hamster strain may regulate the expression bf apoE and 
hence play a role in the catabolism ofTG-rich lipoproteins. We hypothesized that fish oil 
feeding to F 1 B hamsters would result in the down-regulation of apoE protein expression. 
This would provide a plausible case for the variation in the extent of 
hypertriglyceridemia, as well as for the development ofhypertriglyceridemia due to a 
decrease in the clearance of TG-rich lipoproteins. Our hypothesis was primarily based 
upon studies conducted in apoE knockout mice, where fish oil feeding to these mice 
induced hypertriglyceridemia attributed to the absence of apoE (Asset eta!., 2001 ). These 
authors also determined that apoE was necessary for fish oil to actuate its 
hypotriglyceridemic properties. In this study however, our findings were the complete 
opposite of our hypothesis. 
Fish oil-fed hamsters had elevated plasma apoE concentrations compared to those 
hamsters fed the MUF A and N6:N3 diets. The effects of specific fatty acids on plasma 
apoE concentrations are not extensively researched, and we are the first to investigate this 
phenomenon in hamsters. It has been shown however, that subjects fed a fish oil diet 
have significantly lower apoE concentrations compared to baseline (Buckley et al., 
2005). MUF A feeding to adult men has also been shown to decrease apoE concentrations 
compared to diets rich in SF A (Jackson eta!., 2005). 
There are several possible explanations for the observed alterations in apoE 
protein expression. A significant decrease in apoE concentrations is known to reduce the 
clearance, while a small increase will enhance the clearance of TG-rich lipoproteins 
(Zhang eta/., 1992; Matsushima et al., 1999). ApoE however is only considered to be an 
anti -atherogenic apoprotein to a certain extent. Overexpression of apoE at levels of more 
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than 30g/L leads to hypertriglyceridemia (Huang et al., 1998). An increasing body of 
evidence indicates that while apoE is postulated to be required for the functioning of LPL 
(Havel et al., 1984), that elevated apoE induces hypertriglyceridemia through the 
inhibition of LPL-mediated hydrolysis of lipoproteins (McConathy et al., 1989; Oomez-
Coronado eta!., 1993; Rensen et al., 1996). Therefore, our findings suggest that the 
elevated protein expression of apoE may affect the binding of lipoproteins to LPL, 
thereby decreasing the hydrolysis of chylomicrons and VLDL and contributing to the 
elevated postprandial TO concentrations. Furthermore, TO-rich lipoprotein particles are 
known to compete for apoE for subsequent hepatic removal (Westphal et a!., 2000). In 
this case, the increased presence ofVLDL and chylomicron-like particles will compete 
for apoE. In parallel to the competition between these lipoproteins for LPL, the result is a 
decrease in the uptake ofVLDL, chylomicron remnants, or both. 
In addition to the effect of dietary fat on plasma apoE protein expression, there is 
also an obvious difference in the response ofF1B and OS hamsters. Fish oil fed F1B 
hamsters have greater apoE protein expression than fish oil fed OS hamsters, while the 
abundance of apoE protein expression in MUF A and N6:N3 fed F 18 and OS hamsters is 
reversed. In F 1 B hamsters, the relative expression of apoE reflects the plasma 
concentration of TO-rich lipoproteins where elevated apoE-associated lipoproteins such 
as VLDL were elevated in the N6:N3 diet compared to the MUF A diet. In OS hamsters 
however, there is greater expression of apoE in MUF A fed hamsters, which is not 
reflective of plasma lipoprotein concentrations. These findings have not previously been 
reported in either F1B or OS hamsters. In humans however, the existence of various apoE 
phenotypes are known to influence both the response to dietary fatty acids, and the levels 
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of apoE protein expression. The possibility exists then, that this heterogeneity in apoE 
phenotype may present itself in the hamster, considering the presence of both inbred and 
outbred strains. ApoE isoforms have not currently been reported in any animal models. 
Should the existence of apoE isoforms in hamsters be discovered, it would provide a 
novel and unique animal model for the investigation of gene-nutrient interactions. 
4.3 Future Directions 
It has previously been reported that the female parent strain to the F 1B hamster 
has a defect in the regulation of cholesterol metabolism, where cholesterol biosynthesis is 
not under feedback inhibition (Schaffner et al., 1981 ). Thus, investigation into the parent 
strains of both F 1 B and GS hamsters will allow the potential location of genotypic 
differences that may influence strain-specific responses to dietary fat. The quantification 
of apoE in this study would allow for the determination of plasma apoE concentration 
and also indicate ifthere was an actual interference with LPL activity. ELISA kits to 
determine apoE concentration are currently available, but only for the detection of human 
apoE. The development of an ELISA specific to hamster or rodent apoE would allow 
appropriate quantification and a solid answer to our hypothesis concerning the 
overexpression of apoE. 
Further investigation into the role of specific apolipoproteins is also necessary, 
particularly those of the apoC family. ApoCII and apolipoprotein CIII (apoCIII) are key 
players in lipoprotein metabolism as they interact with both LPL and apoE to mediate the 
clearance of TG-rich lipoproteins. ApoCII is a ligand necessary for the activation of LPL, 
while apoCIII is known to be an inhibitor of the enzyme. Therefore, a decrease in apoCII 
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or increase in apoCIII concentration or production may account for the differences in 
LPL activity between animal strains. In addition, apoCIII has been shown to interfere 
with the binding of apoE containing lipoproteins to the LDLr due to the displacement of 
apoE. In our study then, elevated plasma apoE concentrations do not necessarily suggest 
that apoE is bound to TG-rich lipoproteins. Western blot analysis was conducted using 
antibodies against human apoCII and apoCIII, however we did not obtain any results as 
these antibodies were not specific for hamsters. Measurement of apoCII and apoCIII 
concentrations and rates of production would provide further insight into the 
dysregulation of lipoprotein metabolism in these hamsters. 
4.4 Conclusions 
The use of three potentially cardioprotective diets yielded a large variation in 
several aspects of lipoprotein metabolism. Fish oil feeding induced severe dyslipidemia, 
accumulation of apoB48- and apoB 1 GO-containing lipoprotein particles after a 14~hour 
fast, and highly elevated plasma apoB and apoE protein concentrations. In contrast, 
hamsters on a diet rich in MUF A had the lowest plasma lipid and lipoprotein 
concentrations, and distinctly lower apoB and apoE protein concentrations. Furthermore, 
a diet containing a beneficial n-6:n-3 ratio significantly lowered plasma lipid 
concentrations and apoprotein expression, however, trends for an increase in plasma lipid 
concentrations in comparison to the MUF A diet indicate that addition of fish oil in the 
diet has an adverse effect on lipoprotein metabolism in F1B and GS hamsters. It is quite 
possible that there are additional components of fish oil that may affect the regulation of 
141 
lipids and lipoproteins in hamsters, however this hypothesis was beyond the scope of this 
thesis. 
Absence of any dietary effect on MTTP activity and elevated apo848 protein 
expression further suggest that the observed dyslipidemia induced by fish oil is a result of 
the hindrance of TO-rich lipoprotein clearance as opposed to the synthesis and secretion 
of these lipoproteins. 
Comparison of the inbred F 1B hamster to the out bred, normal OS hamsters, 
allowed us to partially attribute the fish oil induced hyperlipidemia to diversity in animal 
strain. Decreased LPL concentrations and elevated apoB and apoE protein expression in 
F 1 B hamsters allude to heterogeneity within genetic background that contributes to the 
varied response of these hamsters to dietary fat. Further investigation into lipoprotein 
metabolism in these strains will lead to a more detailed understanding of the link between 
phenotype and dietary fats. Further identification of polymorphisms within each animal 
strain in response to various unsaturated fats may also provide insight into the diverse and 
controversial effects of fish oil on cholesterol and lipoprotein metabolism in humans. 
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